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ABSTRACT 
The Role of Protein Kinase R in Lipotoxicity 
 
Büşra Yağabasan 
M.Sc.in Molecular Biology and Genetics 
Supervisor Assist. Prof. Dr. Ebru Erbay 
August 2013, 115 Pages 
 
Endoplasmic reticulum (ER) is a central organelle for cellular homeostasis through its myriad 
of functions including protein and lipid biosynthesis, protein folding and secretion and 
calcium homeostasis. When protein folding or secretion is disrupted, ER elicits a unique 
signaling response initiated at its membranes called the unfolded protein response (UPR). 
UPR attempts to restore cellular homeostasis and survival via reducing unfolded protein 
levels, however, if this cannot be achieved or the stress is prolonged the UPR could lead to 
apoptosis. Three specific ER membrane proteins, inositol-requiring enzyme-1 (IRE1), Protein 
Kinase R-resemble like ER kinase (PERK) and activating transcription factor 6 (ATF6), act as 
ER stress sensors and initiate distinct but interlaced signaling pathways to restore ER 
homeostasis. Recently, studies demonstrated that over nutrition, especially high amount of 
saturated fatty acids or cholesterol in the circulation, leads to the induction of ER stress in 
metabolic tissues, resulting in the activation of UPR signaling pathways. Furthermore, ER 
stress was shown to play a causal role in the pathogenesis of metabolic diseases such as 
obesity, insulin resistance, type 2 diabetes and atherosclerosis.  
Interferon inducible double strand RNA activated protein kinase R (PKR) is also known to be 
activated during ER stress. Recent studies showed it can be activated by lipids during ER 
stress in cells and in metabolic tissues of obese mice. Genetic ablation or inhbition of PKR 
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enhances systemic glucose homeostasis and insulin sensitivity in obesity in rodent models. 
However, it is not known how PKR becomes activated by overnutrition or by ER stress. In 
fact, many of the specific cellular components and molecular mechanisms in lipid induced 
cellular stress or death, namely lipotoxicity, is not completely understood. PKR is one of the 
serine/threonine kinase that is known to be activated during lipid induced ER stress, but only 
a few specific downstream substrates are known and these fall short of explaining PKR’s role 
in lipotoxicity in chronic metabolic disease pathogenesis. PKR also plays a crucial role in 
activation of inflammasomes through interacting with the inflammasome components. There 
is a gap in our knowledge regarding PKR’s specific molecular actions in nutrient-induced 
inflammation and metabolism in chronic metabolic diseases.  
In this thesis study, my major goal was to develop specific tools to modulate PKR’s activity 
and search for its specific substrates in lipotoxicity and its role in mediating lipid-induced ER 
stress response. For this purpose, I developed a novel chemical-genetic approach to 
specifically modify PKR’s kinase activity during ER stress. In this approach, the bulky side-
chain of a gatekeeper amino acid (such as methionine) in the ATP binding cavity of PKR has 
been altered to a smaller side-chain amino acid (such as glycine) in order to slightly enlarge 
the cavity to accommodate bulky ATP analogs (activating or inhibiting). This mutant of the 
PKR has been named the analog sensitive kinase allele (ASKA) of PKR and was shown to 
utilize normal ATP as well as the bulky ATP analogs in kinase reactions. Furthermore, I 
demonstrated the specific inhibition of PKR kinase with the inhibitory, bulky ATP analogs 
such as4-Amino-1-tert-butyl-3-(1’-naphthyl)pyrazolo[3,4-d]pyrimidine (NAPP1) or 4-Amino-
1-tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine (1-NMPP1). In order to move 
one step closer to identification of potential PKR substrates, I also optimized kinase reactions 
for immunoprecipitated PKR ASKA mutant and visualized several potential downstream 
substrates in my initial experiments. 
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 Finally, I studied a unique relationship between two ER stress related kinases IRE1 and PKR 
in lipid induced ER stress conditions. I observed specific inhibition of IRE1’s 
endoribonuclease activity with an inhibitor, but not its kinase activity, completely blocks PKR 
activation by lipids. These findings strongly support hat IRE1’s RNAse activity is necessary 
for PKR kinase activation by lipids. This function of IRE1 RNAse domain is novel and 
unsuspected. The future goals of this research should be directed to discovering the RNA 
mediators of IRE1-PKR coupling and understanding their role in mediating the inflammatory 
and metabolic pathologies associated with chronic metabolic diseases. 
In conclusion, in my thesis study, I developed novel chemical-genetic approach to specifically 
modify PKR kinase activity that could be useful in discovering novel PKR substrates. Based 
on the preliminary findings in this thesis, PKR appears to have many unidentified substrates 
regulated during lipid induced ER stress. Furthermore, using the chemical-genetic PKR as a 
tool as well as several other approaches I demonstrated the existence of a unique, functional 
relationship between IRE1 and PKR in lipotoxicity. In addition, the results in my thesis shows 
that IRE1’s endoribonuclease activity is required and sufficient for PKR kinase activation by 
lipids. These findings and tools developed during my studies can be further utilized for 
analyzing the specific role of PKR in lipotoxicity, which is important for the health 
consequences of metabolic diseases.  
 
Key words: UPR, ER stress, PKR, IRE1, Lipids. 
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Protein ve yağ biosentezi, protein katlanması, kalsiyum salgılanması ve dengelenmesini de 
içeren sayısız fonksiyonuyla Endoplazmik Retikulum (ER) hücresel homeostaz için merkezi 
bir organeldir. Protein katlanması ya da salgılanmasıyla ilgili bir bozukluk olduğunda, ER 
zarlarından katlanmamış protein yanıtı (KPY) adı verilen özgün bir sinyal cevabı başlatır. 
KPY düzgün katlanmamış protein seviyesini azaltarak ER homeostazını eski haline getirmek 
için girişimde bulunur, fakat eğer ER homeostazı tekrar elde edilemezse ya da ER stresi uzun 
süreliyse KPY apoptoza yol açabilir. Üç özel ER zar proteini, inositol-gerektiren enzim-1 
(IRE1), Protein Kinaz R’yi (PKR) anımsatan kinaz (PERK) ve aktifleştiren transkripsiyon 
faktör 6 bu yolakta stres sensörü olarak rol alır ve ER homeostazını tekrar sağlamak için ayrı 
fakat birbirinin içine geçmiş sinyal yolaklarını başlatır. Yakın zamanda, çalışmalar gösterdi ki 
aşırı beslenme, özellikle dolaşımda olan yüksek miktarda doymuş yağ asitleri ya da kolesterol, 
metabolik dokularda ER stresini indükler ve bu indüksiyon KPY sinyal yolaklarının 
aktifleşmesine yol açar. Ayrıca ER stresinin obezite, insülin direnci, tip 2 diyabet, ve 
aterosklerozis gibi metabolik hastalıklarının patogenezinde sebepsel bir rol oynadığı 
gösterilmiştir.  
Interferon ile indüklenebilen ve çift sarmallı RNA ile aktifleşen protein kinaz R’nin (PKR) de 
ER stresi sırasında aktifleştiği bilinmektedir.Son çalışmalar ayrıca PKR’nin ER stresi boyunca 
vii 
 
lipidler ile ve obez farenin metabolik dokularında aktifleşebileceğini göstermiştir. PKR’nin 
genetik ablasyon ya da inhibe edilmesi kemirgen modellerdeki obezitede insülin duyarlılığını 
ve sistemik glukoz homeostazını arttırır. Fakat PKR’nin aşırı beslenme ile ya da ER stresiyle 
nasıl aktifleştiği bilinmemektedir. Aslında yağ ile indüklenmiş hücresel streste ya da 
ölümdeki, birçok özel hücresel bileşen ve moleküler mekanizma, yani lipotoksisite tam olarak 
anlaşılamamıştır. PKR yağ ile indüklenen ER stresinde aktifleştiği bilinen serin/treonin 
kinazlarından biridir, fakat sadece birkaç özel substratı bilinmektedir ve bunlar PKR’nin 
kronik metabolik hastalık patogenezindeki lipotoksisitede PKR’nin rolünü açıklamada 
yetersiz kalmaktadır. PKR ayrıca inflamazom bileşenleriyle etkileşime girerek, inflamazom 
aktivasyonunda önemli bir rol alır. PKR’nin kronik metabolik hastalıklarda besin ile 
indüklenen iltihaplanma ve metabolizmadaki özel moleküler eylemlerine ilişkin bilgimizde 
bir boşluk bulunmaktadır.  
Bu tez çalışmasında, benim ana amacım PKR’nin aktivitesini düzenlemek için özel araçlar 
geliştirmek ve onun lipotoksisitedeki özel substratlarını ve yağ ile indüklenen ER stresi 
cevabında oynadığı rolü araştırmaktı. Bu amaçla, PKR’nin ER stresi sırasındaki kinaz 
aktivitesini özel olarak mofidiye etmek için özgün bir kimyasal-genetik yaklaşımı geliştirdim. 
Bu yaklaşımda, ATP analoglarının (engelleyen ya da aktifleştiren) PKR’nin ATP bağlanma 
boşluğuna uyum sağlayabilmesi için PKR’nin ATP bağlanma boşluğundaki iri hacimli yan-
zincir bekçi aminoasit (metiyonin gibi) daha küçük yan-zincir aminoasitine (glisin gibi) 
değiştirilir. PKR’nin bu mutantı ATP analoğuna duyarlı kinaz (AZKA) olarak adlandırılır ve 
bu mutantın kinaz reaksiyonlarında normal ATP’nin yanında iri hacimli ATP analoglarından 
da yararlandığı gösterilmiştir. Buna ek olarak, ben PKR kinazının inhibe eden iri hacimli-
Amino-1-tert-butyl-3-(1’-naphthyl)pyrazolo[3,4-d]pyrimidine (NaPP1) or 4-Amino-1-tert-
butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine (1-NMPP1) gibi ATP analoglarıyla 
inhibe oluşunu gösterdim. Potansiyel PKR substratlarını tanımlamaya bir adım daha 
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yaklaşmak için, ayrıca immünoçökeltilmiş PKR AZKA mutantı için kinaz reaksiyonlarını 
optimize ettim ve başlangıçtaki deneylerimde potansiyel aşağı sinyal yolaklarındaki 
substratlarını görüntüledim.  
Son olarak, yağ ile indüklenen ER stresi koşullarında, iki ER stresi ile ilgili kinasın arasındaki 
özgün ilişkiyi çalıştım. IRE1 kinazının kinaz değil ama endoribonükleaz aktivitesini bir 
inhibitör ile inhibe ettiğimde, yağlara bağlı PKR aktivasyonunun tamamen kaybolduğunu 
gözlemledim. Bu bulgular IRE1 kinazının RNAse aktivitesinin PKR kinazının yağ ile 
aktifleşmesi için gerekli olduğu bilgisini güçlü bir şekilde destekler. IRE1 kinazının RNAse 
bölgesinin bu fonksiyonu özgündür ve umulmadıktır. Bu araştırmanın gelecekteki hedefi 
IRE1-PKR bağlantısındaki RNA aracılarını keşfetmeye ve bu bunların kronik metabolik 
hastalıklarla ilşkili inflamatuar ve metabolik patolojilerdeki rolünü araştırmaya 
yönlendirilmelidir.  
Sonuç olarak, tez çalışmamda, PKR’nin kinaz aktivitesini özel olarak modifiye etmek ve bu 
şekilde özgün PKR substratlarını keşfetmek için özgün bir kimyasal-genetik yaklaşım 
geliştirdim. Bu tezde bulunan ön bulgulara göre, yağ ile indüklenen ER stresi esnasında 
PKR’nin birçok tanımlanmamış substratı var gibi görünmektedir. Buna ek olarak, kimyasal-
genetik PKR’yi kimyasal genetik aracı olarak kullanarak ve başka diğer yaklaşımlarla, 
lipotoksisite esnasında IRE1 ve PKR kinazları arasında benzersiz, fonksiyonel bir ilişkinin 
varlığını gösterdim. Ayrıca, tezimdeki sonuçlar göstermekte ki; IRE1 kinazının 
endoribonükleaz aktivitesi PKR kinazının yağlar tarafından aktifleştirilmesi için gerekli ve 
yeterlidir. Çalışmalarım esnasında geliştirilen bu bulgular ve araçlarında, metabolik 
hastalıkların sağlıksal sonuçları için önemli olan PKR’nin lipotoksisitedeki özel rolünün 
analizi için daha fazla yararlanılabilir.  
 
Anahtar kelimeler: KPY, ER stresi, PKR, IRE1, Yağlar. 
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1. INTRODUCTION 
 
1.1. Endoplasmic Reticulum, Its Structure and Function 
The endoplasmic reticulum (ER) is a central organelle for cellular homeostasis. ER, a 
membrane-bound organelle, is comprised of stacks of tubules and vesicles that connect it to a 
network of other membranous organelles
2
. Two types of ER are classified depending on 
association with or without ribosomes and called rough ER and smooth ER, respectively. The 
rough ER is important for protein synthesis. Secretory and transmembrane proteins are folded 
in the ER lumen and reach maturation before they leave the ER
1
. The smooth ER is the site 
for lipid and sterol synthesis as well as the major intracellular storage site for calcium (Ca
2+
)
3
. 
Furthermore, ER is the merging site for many extracellular and internal signals and 
orchestrates adaptive cellular responses to alternating cellular conditions.  For example, via 
storing or releasing Ca
2+
, ER plays a role in muscle relaxation and contraction, learning and 
memory, metabolism and cell death
2
. 
As the major reservoir for intracellular Ca
2+
, the ER can store up to three to four times more 
Ca
2+
 concentrations than in the cytosol. With the appropriate signal, this concentration 
gradient facilitates the exit of Ca
+2
 from the ER to the cytoplasm through one of the many ER 
membrane channels/receptors, such as Inositol triphosphate receptor (IP3R), leak channels 
and ryanodine receptor (RyR). In direct contrast to this, the sarcoplasmic-endoplasmic 
reticulum Ca
2+
 ATPase (SERCA) pumps take up calcium from cytosol into the ER lumen and 
as a result generate the high calcium gradient between ER and cytoplasm
5
. 
Lots of enzymes and molecular chaperons function in the ER to facilitate its central role in 
protein folding, maturation and secretion. Collectively these are called the reticuloplasmins. 
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Molecular chaperones facilitate proteins folding by increasing the yield of structural 
maturation and folding rather than increasing the rate. One of the ER chaperones known as 
Binding immunoglobulin protein (BiP) also known as 78 kDa glucose-regulated protein 
(GRP-78), recognizes and binds to unfolded proteins through these proteins’ hydrophobic 
(specifically, aromatic) amino acids
6
. BiP also has an ATP hydrolysis function, acts as 
adenosinetriphopshatase (ATPase), it dissociates from its protein ligands when there is ATP. 
BiP/GRP78 protein and 94 kDa glucose-regulated protein (GRP94) bind to immunoglobulin 
heavy and light chains, and these ER stress proteins act as molecular chaperones and work 
together during folding and assembly of proteins
8
. Additionally, there are some ER-resident 
enzymes helping maturation and folding of proteins. For example, protein disulfide isomerase 
(PDI) acts as a catalyst in the formation of disulfide bridges. Another example is the 
calnexin/calreticulin/glycosyltransferase system, which helps the folding of proteins via 
interacting with nascent proteins and plays a role in ER-quality control system
7
. Newly 
synthesized unfolded proteins and proteins that reside in ER lumen are translocated into the 
lumen of the ER via one of the translocons called as Sec61 complex and are folded into 
mature forms with the assistance of molecular chaperones, helper folding enzymes and in the 
presence of high intralumenal Ca
2+
 concentrations. Then, these nascent polypeptides are N-
glycosylated with N-glycosylating enzymes. Finally they mature into secondary and tertiary 
structures with the help of PDI. In addition, N-glycosylation enzymes and lectins also help the 
maturation of proteins
7
. After the mature forms of the proteins pass the ER quality control, 
they are then transported into the Golgi apparatus, whereas the unfolded or misfolded proteins 
are degraded by the highly conserved ER-associated degradation mechanism (ERAD). 
In the ERAD pathway the unfolded proteins translocate into cytosol through the translocon 
channels for proteasomal degradation
11
.  It was also showed that, Sec61 is needed for ERAD-
L pathway which is a specific ERAD pathway that degrades integral unfolded ER luminal 
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proteins
12,13
. There are also other ERAD pathways such as ERAD-C, which is responsible for 
degrading membrane proteins with cytosolic lesions, and ERAD-M, which degrades 
membrane proteins with misfolded transmembrane domains
143
. To conclude, ER plays a 
multitude of important roles to maintain cellular homeostasis including but not limited to 
promoting protein folding, maturation and secretion.  
Another fundamental but less well appreciated function of the ER is in lipid biosynthesis. It is 
the central site for synthesis of cholesterol, ceramides and phospholipids. When intracellular 
cholesterol levels are lowered this leads to activation of the ER resident sterol regulatory 
element-binding protein-1 and 2 (SREBP-1 and 2), which can transcriptionally upregulate the 
expression of key cholesterol synthesis enzymes
15
. When intracellular cholesterol is low, 
SREBP is released from Sterol regulatory element-binding protein cleavage-activating 
proteins (SCAP), which normally tethers SREBPs to the ER membranes. The SREBP can 
then translocate into Golgi to get cleaved and activated as a functional transcription factor. In 
particular SREBP1a and -2 upregulates synthesis of cholesterol, whereas SREBP1c 
upregulates the transcription of key enzymes in fatty acid synthesis pathways
15
. Insulin 
induced gene proteins (Insig-1 and 2), another ER membrane-bound proteins, negatively 
regulate fatty acid synthesis through controlling the activity of SREBP and 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMGCoAR) degradation
14, 144,145
. In the presence of 
high amount of sterols, ER membrane proteins Insig-1 and Insig-2 interacts with HMGCoAR 
and recruits the tumor autocrine motility factor receptor protein gp78, a membrane-associated 
ubiquitin ligase, leading to ubiquitination of reductase. In result, the ubiquitinated reductase is 
degraded by the ERAD pathway
14
. Furthermore, when sterol levels are high, Insig-1 protein 
binds and changes the conformation of SCAP.  Because of this conformational change, 
SCAP-SREBP-Insig-1 complex cannot be translocated to Golgi where SREBP is activated
145
.  
Another key lipid enzyme found the ER membrane is the Stearoyl-CoA desaturase (SCD), a 
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short lived enzyme which is needed for synthesizing monounsaturated fatty acids. SCD acts 
as a key component in hepatic synthesis of very-low-density proteins and triglycerides
16
. Also 
on the ER membrane, Diaclylycerol transferases (DGATs), act as catalysts in the final step of 
triacylglycerol (TAG) synthesis’17. The ER-bound Acyl-coenzyme A: cholesterol 
acyltransferases (ACAT) catalyze the formation of cholesterol esters from cholesterol
18
. Some 
ER enzymes such as DGATs and acyl-CoA: sterol acyltransferases (ASATs) for steryl esters, 
act as catalysts in elongating fatty acid synthase synthesized palmitate product, which is 
beyond 16-C length. They also lengthen dietary polyunsaturated fatty acids synthesized by 
fatty acid synthase. Desaturases such as Delta6-desaturase, and some ER-resident proteins, 
NADH-cyt b5 Reductase and Cytochrome b5 take role in formation of double bond in fatty 
acids
20
. To sum up, ER functions in lipid biosynthesis through these specific ER enzymes that 
regulate many cellular signaling pathways important in lipid biosynthesis.  
Another essential role ER plays in lipid biology is contribution of the membrane components 
of the lipid droplets. Lipid droplets are major intracellular reservoir of mainly triacylglycerols 
(TAGs) and cholesterol esters (CEs). They consist of a hydrophobic neutral core containing 
these TAGs and CEs, surrounded by a phospholipid monolayer and cholesterol
21
. In addition, 
ER luminal proteins calnexin and BiP were detected in lipid droplet fractions
22
,
147
. Still there 
is limited information about lipid droplet assembly and expansion mechanisms and most 
models remain theoretical. Researchers strongly came up with two specific models for lipid 
droplet formation. These are the classical model and the hatching model. In the classical 
model, the budding lipid droplet is surrounded by the cytoplasmic leaflet of the ER 
membrane
25
. As ER luminal proteins calnexin and BiP association with lipid droplet was 
shown, Plough proposed another model for lipid droplet formation called Hatching model. In 
this model, lipid droplet is covered by phospholipid monolayer, with both cytosolic and 
luminal leaflets of ER membrane, this structure is bicellar structure
22
. This model also 
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supports the role of lipid droplet in misfolded protein degradation, as lipid droplet associates 
with luminal ER protein, BiP, bind to misfolded proteins and target them for degradation
147
. 
Recently, it was shown that several ER-resident lipid enzymes including the neutral lipid 
synthetic enzymes diacylglycerol acyltransferase 1 (DGAT) or 1-acylglycerol-3-phosphate 
acyltransferase (AGAT) also have role in lipid droplet formation
24
. Furthermore, it was shown 
that ER Glycerol-3-phosphate acyltransferase 4 (GPAT4) relocalizes from ER to lipid 
droplets and mediates their expansion
2
. Therefore, it can be concluded that ER functions in 
lipid droplet formation with specific ER enzymes and structural proteins which functions in 
formation of lipid droplets
22,147
. 
Besides ER’s general functions that have been discussed, in the pancreatic beta cells ER 
assumes an especially important metabolic role in pro-insulin biosynthesis. The freshly 
translated insulin mRNA prepro-insulin gets translocated into the lumen of the ER, where ER 
proteases cleave off the signal peptide of turning prepro-insulin into pro-insulin. Then pro-
insulin is further folded by ER-enzymes via forming intramolecular double disulfide bonds. 
The properly folded pro-insulin is then translocated to Golgi and transferred into secretory 
granules. In secretory granules, pro-insulin is converted to mature insulin and released by 
exocytosis
26
. When the ER is stressed, however, insulin transcription, translation and 
secretion get blocked through several mechanisms involving the ER based stress response 
pathway
26
. 
1.2. Endoplasmic Reticulum Stress 
1.2.1. The Causes and the Consequences of Endoplasmic Reticulum Stress 
ER is a central homeostatic organelle that functions in membrane protein and lipid 
biosynthesis, calcium homeostasis, secretion, folding and maturation of proteins
41
. If the ER 
cannot adapt to the ever-changing intracellular conditions, such as a dramatic increase in 
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unfolded or misfolded proteins, it undergoes an elaborative stress response called Unfolded 
Protein Response (UPR)
41
. ER stress can be induced by many other physiological and 
pathological stimuli such as environmental toxins, glucose deprivation, elevated saturated 
lipids or free cholesterol, viral infections, defects in protein trafficking, mutations in 
chaperone genes, aberrant calcium regulation, hypoxia and complex conditions associated 
with aging and tumorogenesis
27,3,28
. When ER stress is induced, unfolded proteins are 
identified through the Endoplasmic Reticulum Quality Control (ERQC) mechanism
30
. 
Specifically, calreticulin, calnexin and BiP chaperone proteins identify the unfolded proteins 
by the surface exposure of their hydrophobic sites, reactive thiols and immature glycans and 
bind these proteins to promote their proper folding
30
. Once these proteins are refolded they are 
released from the ER. Defects in the N-linked glycosylation pattern are also carefully 
monitored and such proteins become targets for ER α-mannosidases, following degradation-
enhancing α-mannosidase-like protein (EDEM) binding to them30. These are then translocated 
to cytoplasm and degraded via the ERAD pathway
12,29,30
. 
ER stress can be viewed in three phases: acute, periodic and chronic
32
. The most widely 
studied form is the acute form, which can be experimentally induced via chemical treatments 
such as tunicamycin (protein glycosylation inhibitor), thapsigargin (SERCA pump inhibitor) 
and Dithiothreitol (DTT) (protein disulfide bond inhibitor)
32
. Exposure to toxic levels of 
saturated fatty acids or free cholesterol can also induce acute ER stress, whereas simultaneous 
treatments with unsaturated free fatty acids like oleate and palmitoleic acid can block this 
response
32
. Rhythmic or transient physiological activities such as feeding-fasting cycle, or 
transient glucose/lipid infusions induce the ―periodic‖ type of ER stress, and after each cycle, 
ER homeostasis is fully restored with help of UPR
32
. And the final form of ER stress is the 
―chronic‖ form and in which ER homeostasis is never fully achieved in the continuous 
presence of ER-stress inducer leading to uninterrupted UPR signaling
32
. Chronic ER stress is 
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widely observed in metabolic diseases such as insulin resistance, obesity, dyslipidemias and 
atherosclerosis, in which the ER stressor being chronic nutrient excess
32
. Extended exposure 
to saturated fatty acids and cholesterol, lead to chronic, lipotoxic ER stress, which cannot be 
easily resolved
32
. A recent study in obese mice documenting reduction in ER protein synthesis 
and increase in lipid biosynthesis underscores the pivotal changes that occur around ER 
metabolism upon chronic, nutrient excess. Furthermore, the same study shows the alterations 
in ER lipid metabolism is coupled to the inhibition of SERCA activity and causally associated 
with chronic ER stress
31
.  
1.2.2. The Unfolded Protein Response 
The UPR is an elaborative, adaptive, intracellular signal transduction pathway initiated as a 
response to ER stress and first described in mammalian cells by Kozutsumi and colleagues in 
1988
27, 33
. In this study, investigators noted that expression of two ER-stress resident, glucose 
modulated proteins; GRP78/BiP and GRP94 are induced upon the accumulation of misfolded 
proteins at high temperatures
33
. In the same study, expression of wild type and mutant forms 
of influenza virus haemagglutinin (HA) protein in simian cells also lead to upregulation of the 
GRP78/BiP and GRP94 expression
33
. Unfolded protein response pathway was first described 
in yeast; a 22 base pair, cis-acting element (UPR element) was found sufficient for the 
induction of KAR2 (BiP) gene transcription by the accumulation of unfolded proteins
34
. Later 
it was shown that this UPR element is found in the promoter regions of five UPR target genes 
in yeast (karyogamy gene (KAR2) (homolog of BiP), protein disulfide isomerase gene (PDI1), 
protein disulfide isomerase EUG1 gene (EUG1), peptidylprolyl isomerase family gene 
(FKB2), and LHS1 Hsp70 family chaperone gene (LHS1)) and is required for their induction. 
Finally, the molecular UPR pathway was described upon the discovery of the yeast Hac1p, a 
UPR- activated transcription factor which binds to these UPR elements and activates the 
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transcription of ER chaperone proteins
39,40
. Hac1p is a basic-leucine transcription factor, 
which binds to UPR elements on genes that encode ER molecular chaperones
38
. 
Peter Walter and his colleagues also identified IRE1, the key ER membrane protein that 
processes and activates Hac1p, in S.Cerevisae
35
. The human homolog of IRE1 gene, ERN1, 
encodes 1115 aminoacid length transmembrane kinase, Ire1p. Its glycosylated N-terminal side 
lies inside microsomes and its C-terminal cytosolic side has kinase activity
36
. Besides being 
kinase, Ire1p also has an endoribonuclease activity, which is responsible for the cleavage and 
activation of HAC1 mRNA
37,38
.  
Historically, yeast IRE1 is the first discovered and conserved arm of the UPR that leads to the 
activation of XBP1 and production of molecular chaperoes
50,28
. In mammalian cells, in 
addition to the IRE-1, two additional UPR branches maintain ER homeostasis and are 
regulated by two ER membrane-bound proteins:  PKR-like eukaryotic initiation factor 2 α 
kinase (PERK) and activating transcription factor 6 (ATF6)
27
. (Figure 1.1) A well-excepted 
model suggests that in homeostasis conditions, the molecular chaperone BiP/GRP78 interacts 
with PERK and IRE1 to keep them in an inactive state
27
. When ER homeostasis is disrupted, 
BiP/GRP78 dissociates from both PERK and IRE1 in order to bind to unfolded proteins. 
These kinases are thus activated and initiate the UPR
41
. 
When ER homeostasis is disrupted, depending on the degree of disruption, adaptive or 
destructive downstream signaling pathways are activated upon the oligomerization and 
activating auto phosphorylation of IRE1 and PERK. In addition, ATF6 transcription factor 
translocates to Golgi, where it was cleaved by a serine protease site -1 protease (S1P), the 
metalloprotase site-2 protease (S2P) and it becomes fully activated. (Fig 1.1)   
 
9 
 
 
Figure 1.1. ER Stress and UPR pathway. 
(reprinted with permission from Peter Walter and David Ron (2011) The Unfolded Protein Response: From 
Stress Pathway to Homeostatic Regulation. Science Reviews. Science 25 November 2011: Vol. 334 no. 6059 pp. 
1081-1086 DOI: 10.1126/science.1209038.
41
) When there is ER stress, cell elicits a unique response called 
Unfolded Protein Response. During unfolded protein response three ER stress sensors PERK (PKR resemble ER 
kinase), activating transcription factor 6 (ATF 6) and Inositol requiring enzyme 1 (IRE1) are activated which 
represent three distinct arms of UPR. PERK and IRE1 are activated through auto phosphorylation and ATF6 is 
activated through cleavage by specific Golgi proteases S1P and S2P and when activated acts as transcription 
factor via upregulating UPR target genes’ expression49,76,81.When PERK is activated, it phosphorylates eIF2α, 
leading to translational inhibition and specific ATF4 mRNA translation. ATF4 acts as transcription factor and up 
regulates chaperones’ genes expression such as XBP1 and CHOP. IRE1 splices XBP1 mRNA through its 
RNAse activity and leads to its translation and translated XBP1 protein acts as transcription factor via 
upregulating chaperones’ lipid synthesis’  ERAD proteins’ gene expression41. 
 
The first discovered arm of the UPR is regulated by IRE1 and conserved from yeast to 
mammals. There are two types of mammalian IRE1, which has differential tissue expression 
pattern. IRE1α is expressed in many tissues such as liver, skeletal muscle, lung, placenta and 
particularly in pancreas, whereas IRE1β is only expressed in intestinal epithelia51,52. For 
activation, IRE1 first homo-oligomerizes and then auto-phosphorylates itself at serine 724 in 
its C-terminal kinase domain
53
. The only known substrate of IRE1 kinase is itself. Besides its 
kinase activity, IRE1 also has a unique endoribonuclease activity, which cleaves HAC1 
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mRNA in yeast or the homologous XBP1 (X-box binding protein) mRNA in metazoans
53,54
. 
The cleavage of the 26 nucleotide from the intron of XBP1 produces 41 kDA size, active 
XBP1 transcription factor. IRE1 also nonspecifically cleaves mRNAs on ER membrane in 
order to reduce protein synthesis and loading of protein synthesis to ER (IRE1 dependent 
mRNA decay pathway (RIDD). Recently, it was shown that IRE1α endoribonuclease 
(RNAse) domain also leads to fast decay of pre-miRNAs 17, 34, 96 and 125. These miRNAs 
all target caspase-2 mRNA translation.  Therefore it can be concluded that, under ER stress 
conditions, IRE1α positively regulates expression of apoptotic Caspase-2 protein via 
inhibiting maturation of select miRNAs that have role in mediating the apoptotic outcome of 
UPR
58
. 
Active XBP1 transcription factor up regulates the expression of UPR target genes including 
ER chaperones, ERAD proteins and ER membrane expansion related phospholipid 
synthesizing enzymes
54,55
. Furthermore XBP1 can work in coordination with ATF6 to induce 
the heat shock protein 40 member DnaJ (Hsp40) homolog, subfamily C, member 3 protein 
P58IPK. This protein assists in protein folding by behaving like a co-chaperone and 
furthermore, can bind and inhibit PERK and PKR activities
49, 142
.   
Additionally, IRE1 is known to interact with adaptor proteins like such as TNF receptor-
associated factor 2 (TRAF2) in order to stimulate apoptosis signal regulating kinase (ASK1). 
ASK1 activates the pro-apoptotic cJUN NH2-terminal Kinase (JNK), p38 mitogen activated 
kinase (p38MAPK) and caspase 12
57
.  Under normal conditions caspase 12 is bound and 
inactivated by TRAF2, but when there is ER stress caspase 12 dissociates from TRAF2 
complex and this activated form leads to cell death 
57 
. IRE1 also through interaction with 
TRAF2 regulates JNK-AP1 and nuclear factor қB (NF-қB) pathways (Figure 1.2). Finally, by 
activating JNK, IRE1 can indirectly regulate insulin synthesis proteins Insulin receptor 
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substrate 1 (IRS1) and Insulin receptor substrate 2 (IRS2) via its JNK-induced inhibitory 
phosphorylation
28
. 
 
 
Figure 1.2. IRE1 arm of the Unfolded Protein Response.  
(reprinted with permission from Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum 
unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529. © Nature publishing Group, 200750.). In the 
presence of ER stress, IRE1 oligomerizes and autophosphorylates itself, leading to its activation
50
. After it is 
activated, through its RNAse domain, it splices XBP1 mRNA, which is then translated and acts as a transcription 
factor for expression of chaperones’, lipid synthesis’ and ERAD proteins’ genes50. It also interacts with TRAF2 
through its kinase domain resulting in its activation and activated TRAF2 starts a signaling cascade, interacts and 
activates mitogen activated protein kinases leading to insulin resistance
154
. It also interacts with Caspase-12 
leading to cell death
50
.  
 
The second UPR arm is maintained by PERK. PERK is a type I transmembrane 
serine/threonine kinase which has N-terminal luminal ER stress sensor and a cytosolic kinase 
domain. Similar to IRE1 activation mechanism, PERK can oligomerize and auto 
phosphorylate (at threonine 981) upon dissociation of BiP
42
. PERK shares similarities with 
the three other eIF2α phosphorylating kinases at its C-terminal kinase domain43. The other 
eIF2α  kinases are the interferon inducible viral infection derived double strand RNA 
activated Protein Kinase R (PKR), the amino acid deprivation activated general control non-
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depressible kinase 2 (GCN2) and the heme regulated eif2α kinase (HRI)43 . Eif2α is a key 
protein that controls protein translation mechanism by transporting the initiator methionyl-
transfer RNA (met-tRNA) to the ribosome in order to initiate protein translation
44
. When 
PERK is activated, it inactivates eukaryotic initiation factor 2 α (eIF2α) through 
phosphorylating it at Serine 51 site and thus, resulting in general protein translation inhibition. 
In this way, PERK reduces protein overload in the ER to alleviate ER stress. (Figure 1.3). 
PERK activity also induces activation of the nuclear factor kappa β (NF-қB) genes45. NF- қB 
has many functions especially as a key regulator of inflammation
50
. eIF2α phosphorylation 
leads to phosphorylation and translational suppression of inhibitory kappa B (IқB) resulting in 
release of inflammatory cytokines such as IL-6 and TNF-α46,47. Another protein PERK 
associates and phosphorylates is the Nuclear erytroid factor 2
28
. Phosphorylation of the 
Nrf2/Keap1 (Kelch-like ECH-associated Protein 1) complex leads to Nrf2 dissociation and 
transport to nucleus
28,
. Nrf2 is a transcription factor that has role in eliciting antioxidant 
response
146
. In contrary with its role in general protein translation inhibition, PERK activates 
Activating Transcription Factor-4 (ATF-4) translation leading to the transcription of UPR 
target genes and chaperones (Figure 1.3)
27,41
. ATF4 stimulates transcriptional activation of 
apoptosis, inflammation, glucose metabolism, ER redox control, negative feedback eIF2α 
phosphorylation inhibitory genes
28
. Transcription factor C/EBP homologous protein also 
called CCAAT/enhancer binding proiculutein (CHOP)
 41
 and growth arrest- and DNA damage 
inducible- 34 (GADD34)
 41
 , ER redox control (ERO1) and activating transcription factor 3 
(ATF3) are four gene targets of ATF4
28,44
. GADD34 interacts with catalytic subunit of protein 
phosphatase (PP) and dephosphorylates eIF2α relieving its inhibition, leading to translational 
recovery
44
. Ero1 functions in balancing the redox potential in the ER
191
. CHOP is a 
transcription factor which regulates activation of apoptosis genes. ATF6 stimulated P58IPK 
interacts with cytosolic domain of PERK and leads to repression of its activity
48,49
. P58IPK is 
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expressed several hours after PERK activation, this shows that in the end of UPR P58IPK 
expression is induced and cells go apoptosis
48,49
. Therefore, it can be observed that besides its 
protective role and maintaining ER homeostasis through up regulation of UPR chaperones’ 
expression to relieve ER stress, PERK can also contribute to cell death pathways when ER 
stress is prolonged
48,49,50
.  
 
Figure 1.3. PERK arm of the Unfolded Protein Response.  
(reprinted with permission from Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum 
unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529. © Nature publishing Group, 200750.). In the 
presence of ER stress, PERK is activated through auto phosphorylation, leading to phosphorylation and 
inactivation of eIF2α. Besides leading to translational suppression, eIF2α results in ATF4 mRNA translation, 
therefore leading to UPR/ISR target genes expression such as XB1 and CHOP 
62,45,149
. CHOP then acts as 
transcription factor resulting in activation of GADD34, ERO1 genes and cell death genes expression 
61,65,66,67
. 
 
ATF6 is another proximal sensor in the ER stress response and responsible for the initiation of 
the third branch of the UPR
50
. ATF6 is a 90 kDA Basic Leucine Zipper (bZIP) protein, which 
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is activated after cleavage by specific Golgi-resident proteases
50
. When ER stress is induced, 
ATF6 is reduced, and this monomeric, reduced ATF6 translocates to the Golgi, where it is 
cleaved by site-1 and site-2 protease (S1P and S2P)
50
. These proteases specifically cleave 
ATF6 from the luminal domain and its trans-membrane anchor. The active ATF6 (50 kDA 
after cleavage) translocates to the Golgi and binds to promoters that contain ER stress 
response element (ERSE; CCAAT(N)9CCACG), which are found in genes like ERAD 
pathway proteins, lipid biosynthesis, and ER chaperones
59
. There are two isoforms of ATF6, 
ATF6α and ATF6β which become activated with ER stress. Studies show that ATF6 also 
induces the expression of XBP1
59
 and P58IPK, thus intercepting both the IRE-1 and PERK 
branches
49
.  On the other hand, the Wolfram Syndrome 1 (WSF1) protein can regulate ATF6 
activity via targeting ATF6 for ubiquitylation and proteasomal degradation by HMG-CoA 
reductase degradation protein 1 (HRD1) and E3 ubiquitin ligase
60
. Recently, it was showed 
that ATF6 indirectly down regulates  B-cell lymphoma 2 (BCL-2) family member myeloid 
cell leukemia sequence 1 protein (MCL-1) in myoblast cell line, pointing out the potential role 
of ATF6 in initiating apoptosis during ER stress
61
. It was also shown that, homologs of ATF6 
like cAMP responsive element binding protein 3-like 3 (CREBH), old astrocyte specifically 
induced substance (OASIS), basic leucine zipper transcription factor (LUMAN also known as 
LZIP), cAMP responsive element binding protein 3-like 4 (CREB4) and box B-binding factor 
2 human homolog on chromosome 7 (BBF2H7) are also similarly proteolytically cleaved in 
Golgi and give different responses under ER stress. (Figure 1.4)
50
. 
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Figure 1.4. ATF6 branch of unfolded protein response.  
(reprinted with permission from Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum 
unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529. © Nature publishing Group, 200750). In the 
presence of ER stress, ATF6 dissociates from BiP and is transported to Golgi apparatus together with 
CREBH
49,76,81
. The lumenal site-1 protease and the intra-membrane site 2 protease cleave CREBH and ATF6 to 
activate these transcription factors
76,81
. These activated transcription factors then translocate to nucleus leading to 
ATF6 activation of UPR target genes and CREBH activation of acute phase genes’ expression. 
 
1.2.3. The Unfolded Protein Response Outputs: Adaptive or Pro-Survival, Destructive 
or Pro-Apoptotic 
The accumulation of unfolded proteins in the ER activates the UPR
50
. UPR first tries to 
restore folding process by inducing transcription of ER chaperones and ERAD proteins and 
reducing protein overload by inhibiting general translation
61
. It also promotes cell cycle arrest 
in G1 phase
148
. However if ER stress is prolonged, this response also results in apoptosis
61
.  
There are many UPR mediated mechanisms for adaptation to ER stress. For example, PERK 
phosphorylates eIF2α, resulting in translational inhibition and reduction of the protein 
overload in the ER
50
.  In addition, PERK activation leads to cell cycle arrest through the loss 
of short-lived cell cycle regulatory proteins, such as CyclinD1
62
. Even though general 
translation is inhibited as a result of PERK’s activity, certain select mRNAs’ translation 
continues in an increased manner due to their special regulation under the UPR
149
. One such 
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mRNA is ATF4 mRNA, whose translation increases in an eIF2α phosphorylation-dependent 
manner
149
.  
ATF4 translocates to nucleus and activates expression of many genes which then help restore 
ER homeostasis and provide amino acid sufficiency
149
. PERK also activates NRF2 by 
phosphorylation and leads to its dissociation from KEAP1
45,63
. Nrf2 then translocates into the 
nucleus and activates the expression of many antioxidant genes. This constitutes an important 
adaptive mechanism governed by PERK as NRF2 deficient cells showed increased rate of 
apoptosis under ER stress
63, 45
.  
Other adaptive responses to ER stress are managed by the ATF6 arm. After its activation, 
ATF6 translocates into the nucleus and induces the expression of many genes that encode ER 
chaperone and ERAD proteins
61
. ATF6 also induces XBP1 transcription, which is another 
important factor for cell survival
52
.  
The IRE1 arm also has a significant role in eliciting adaptive response. The main adaptive 
response of IRE1 is mediated by the spliced XBP1 mRNA, which generates the active XBP-1 
transcription factor. XBP1 is a transcription factor that induces many genes that have role in 
protein folding and ERAD pathway
64
. XBP1 also regulates ER folding capacity itself
64
.  
Not all outcomes governed by UPR favor the cell’s survival. UPR can also promote apoptosis 
when ER stress is prolonged
62,63,66,67
. For example, PERK activates ATF4, which transcribes 
the CHOP gene, an activating transcription factor in apoptosis. CHOP down regulates 
transcription of anti-apoptotic BCL-2 and it up regulates pro-apoptotic BH3-only protein 
Bim
65,66
 and pro-apoptotic death receptor DR5 expression
65,66,67. ERO1α, GADD34 and 
telomere repeat binding factor 3 (TRB3) are many other CHOP target genes have role in cell 
death mechanisms
61
. Recently, it was shown that the ATF6 arm also has an indirect role in 
triggering apoptosis via down regulation of anti-apoptotic BCL-2 family member MCL-1 in a 
myobast cell line
61
. Furthermore, studies also show that eventually IRE1 is turned off in 
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prolonged ER stress, whereas PERK arm remains on, suggesting the anti-survival role is 
dominated by PERK in continuous stress
50
. Nevertheless, IRE1 can also be pro-apoptotic by 
interacting with tumour necrosis factor receptor-associated factor 2 (TRAF2) and leading to 
Apoptosis signal-regulating kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK) activation, 
which result in apoptotic death
57
. Under ER stress, JNK phosphorylates and suppresses BCL-
2
150
 and B-cell lymphoma extra-large protein (BCL-XL)
150
 anti-apoptotic activity and it also 
phosphorylates BH3 interacting-domain death agonist protein (BID) and proapoptotic BH3-
only protein BIM, making these pro-apoptotic proteins active
151
. Recently Han et al., showed 
that IRE1 dependent RIDD pathway also have role in induction of cell death in the pancreatic 
beta cell line (INS-1)
68
. 
1.3. The Relationship between Endoplasmic Reticulum Stress and Inflammation 
Unfolded protein response is associated with inflammation through multiple mechanisms 
including interaction of the UPR branches with JNK and NF- қB pathways, by promoting ER 
ROS production and Nitric Oxide formation during ER stress and inflammation
28
.These 
pathways also play a major function in sterile inflammation observed metabolic diseases such 
as obesity, atherosclerosis, insulin resistance and diabetes
69
. Recent studies show that UPR 
signaling pathways result in production of many proinflammatory cytokines, through multiple 
mechanisms
69. 
The historically first discovered and conserved branch of UPR, IRE1 pathway 
activates JNK leading to activation of the transcription factor activator protein 1 (AP1)
69,70
. 
AP1 translocates to the nucleus and activates transcription of inflammatory genes including 
tumor necrosis factor (TNF), keratinocyte growth factor (KGF), granulocyte macrophage 
colony (GM-CSF), interleukin-8 (IL-8) and some other cytokine receptors
70
. IRE1 also 
regulates inflammation related Mitogen activated protein kinase p38 and extracellular signal 
related kinase (ERK) via binding to non-catalytic region of tyrosine kinase adaptor protein 
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Nck
71
. Additionally, IRE1 signaling can interfere with NF-κB pathway by interacting with 
inhibitory IκB kinase (IKK) through TRAF2 complex50. Recently it was shown that IRE1 
kinase activity and not endoribonuclease activity activates NF-κB pathway through 
interacting with TRAF2/IKK complex and maintaining IKK activity
72
. Also shown was that 
in JNK deficient cells, tumor necrosis factor alpha (TNF-alpha), interleukin (IL6) and 
monocyte chemotactic protein-1 (MCP-1) proinflammatory cytokines’ expression are 
repressed
28,152,153,154
. As IRE1 can lead to the activation of JNK, it could induce the 
transcription of these pro-inflammatory cytokines
28
. Moreover, XBP1, downstream of IRE1, 
is necessary for B cells to secrete antibody, when they are induced with antigen
73,74
. XBP1 
also has a role in production and release of antimicrobial peptides from Paneth cells
73,74
. NF- 
κB has also been shown to be regulated by the PERK arm through eif2α mediated inhibitor 
kappa B (IқB) translation suppression that results in NFқB activation46,50,160. Without IқB 
present, NFқB translocates to the nucleus and induces expression of inflammatory cytokines69. 
The third UPR arm, ATF6, has also been shown to activate NF-κB via Akt during subtilase 
cytotoxin induced ER stress
75
 ATF6 appears to play an additional role in initiation of acute 
phase response (APR), a highly complex inflammatory process observed at the onset of 
serious diseases such as infection, trauma and inflammation
69
. One study shows that in the 
liver, cyclic-AMP responsive element binding protein H (CREBH) cooperates with ATF6 in 
APR activation
76
.  
Another link between ER stress and inflammation appears to be the ER-generated reactive 
oxygen species and oxidative stress
45
. Depending on UPR, Ero1p and endoplasmic reticulum 
flavin-linked sulfhydryl oxidase (Erv2p) enzymes up regulate chaperone proteins’ expressions 
through forming disulfide bonds in proteins
77
. These enzymes can also reduce molecular 
oxygen. This reduced molecular oxygen leads to oxidative stress and ER stress
77
. The 
activation of PERK then initiates anti-oxidant response with help of Nrf2 activation by 
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PERK
45
. Moreover, ER stress induces the transcription of inducible nitric oxide synthase 
(iNOS) via NF-κB activation, but which of the UPR arms is responsible remains unknown78. 
1.4. The role of Endoplasmic Reticulum Stress and Endoplasmic Reticulum Stress 
related Metabolic Diseases 
Over the past decade we have reached an understanding on the importance of ER homeostasis 
for metabolic well-being and an important target to prevent chronic, inflammatory and 
metabolic diseases such as obesity, diabetes, insulin resistance, fatty liver and 
atherosclerosis
32,155
. Early studies showed that the UPR arms are activated in the liver and 
adipose tissue of rodents during obesity and its reduction by chemical chaperons can prevent 
insulin resistance and metabolic disease
32,79,155. These landmark studies by Hotamisligil’ 
group were also extended to human obesity and has led to many groups to embark on research 
to understand the role of and the molecular mechanisms leading to ER Stress and UPR in 
chronic metabolic diseases
157,158,159
.  
Several mechanisms have been demonstrated regarding how ER stress is tied to the 
development of insulin resistance and diabetes in obesity. For example, upon induction of 
UPR, JNK-AP1 pathway is activated in an IRE1-dependent manner. JNK has been shown to 
phosphorylate the insulin receptor substrate 1 (IRS1) at Serine 307 position, leading to the 
disruption of insulin signaling and promoting insulin resistance
80
. PERK also increases JNK 
activity, through unclear mechanisms
28
. Additionally, ATF6
75
 and PERK
46
 activate NF-κB, 
which then transclocates into the nucleus and induces the expression of pro-inflammatory 
cytokines
50,190
. Other UPR-activated transcription factors can directly modulate expression of 
key lipogenic and gluconeogenic enzymes that contribute to the development of insulin 
resistance. For example, SREBP-1c
161,162,163
, XBP1
160
, and NRF2
164,165
 are such transcription 
factors that can lead to abnormal expression of lipogenic genes. On the other hand, CREBH 
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upregulates gluconeogenic genes while ATF6 and XBP1 downregulate their expression to 
promote insulin resistance
81
. UPR may also indirectly promote hepatic insulin resistance and 
hepatic steatosis via leading fat accumulation in the ER and inhibition of VLDL export 
through disrupting VLDL production by increasing apolipoprotein B100 (apoB100) 
degradation
81,169,170
. PERK- activated ATF4 is another factor that disrupts insulin signaling 
via activating the pseudokinase tribbles homolog 3 (TRB3) expression that negatively 
regulating protein kinase B (PKB), downstream component of the insulin signaling pathway
82
. 
ER stress can be caused by hepatic steatosis in ob/ob mice and this stress results in proteolytic 
cleavage of SREBP1c and SREBP2 transcription factors which upregulates sterol synthesis
163
. 
When BiP is overexpressed adenovirally in hepatocytes of ob/ob mice, SREBP1c activation 
decreases resulting in reduced hepatic triglycerides, and improved insulin sensitivity
163
.  
Additionally, it was showed that XBP1 deficient mice developed insulin resistance upon high 
fat diet induced obesity
79
.In hepatocytes, depending on insulin signaling, heterodimer 
structure formed by the regulatory subunits of phosphotidyl inositol 3-kinase (PI3K), p85α 
(encoded by Pik3r1) and p85β (encoded by Pik3r2) is altered leading to interaction of p85α 
and p85β with XBP1s. Then this p85-XBP1s complex translocates to nucleus, resulting in 
activation of expression of UPR target genes
167
. In insulin resistant, ob/ob mice, the XBP1s-
p85 interaction is disrupted and when p85 is overexpressed in these mice, translocation of 
XBP1s to nucleus is retained, and glucose tolerance is improved
167
.According to a recent 
study, XBP1 was also shown to regulate gluconeogenic transcription factor Forkhead box 
protein O1 (FoxO1) resulting in affection of glucose homeostasis in obese mice
166
. 
Independent from its role in UPR, XBP1 improves glucose homeostasis through 
ubiquitination and degradation of FoxO1 in obese mice
166
. To sum up, XBP1 can improve 
insulin sensitivity through inducing UPR target genes’ expression such as Dnajb9168. It can 
21 
 
also improve glucose tolerance in insulin resistant ob/ob mice by blocking gluconeogenesis as 
it interacts and degrades FoxO1
166
.   
ER stress is also observed in adipose tissue of obese individuals. ATF6-regulated chaperones’ 
expression
158, eif2α phosphorylation158 and expression of IRE1157 together with JNK157 and 
XBP1s
157
, increase in adipose tissue of obese individuals. In one research, it was shown that 
several ER-stress related proteins such as calreticulin, protein disulfide-isomerase A3, 
glutathione-S-transferase, calnexin, JNK-1 and XBP1s are upregulated in subcutaneous 
adipose tissue of obese individuals
172
. This result shows UPR activation in subcutaneous 
adipose tissue of humans
172
. 
 Even researchers showed the presence of ER stress in mouse skeletal muscle after high fat 
diet for 4 weeks
173
, the relationship between ER stress and insulin resistance is more complex 
compared to other tissues. For example, UPR elements’ expression levels remain unchanged 
in muscle tissue after HFD, however insulin resistance and lipogenesis increases
174
. 
Interestingly, researchers showed that single physical exercise causes ER stress in muscle 
whereas exercise training result in adaptive UPR through peroxisome proliferators-activator 
receptor gamma coactivator-1 alpha (PGC-1α)  dependent coactivation of ATF6175. 
Interestingly, it was demonstrated that, in human myotube cells, when palmitate inducible 
Stearoyl-CoA Desaturase 1 (SCD1) expression increases. Depending on the high inducibility 
of SCD1 expression depending on palmitate treatment, insulin sensitivity also increases
176
.  
The increase in IRE1 and PERK phosphorylation together with JNK and BiP activity seen in 
the liver and adipose tissue of obese mice, suggested similar signs of ER stress may be 
evident in the brain.  Indeed, a study showed ER stress leads to the activation of the NFκB 
pathway and inflammation in the hypothalamus, by engaging the Toll like receptor signaling
83
. 
Saturated free fatty acids, such as palmitate lead to activation of mostly TLR4 and modestly 
TLR2
177
. It is not clear; however, what is the direct ligand that stimulates hypothalamic Toll 
22 
 
like receptors
177. After TLR4 and TLR2 are activated, they activate JNK and IκB kinase 
resulting in inflammation and leptin/insulin resistance
177
. Furthermore, chemical chaperone 
application inhibited NFκB signaling and reduced leptin- resistance84. Another recent research 
demonstrated that unsaturated fatty acids as well as chemical chaperones can revert high fat 
diet induced hypothalamic inflammation and can reduce body mass and adipocity
178
.  In 
addition, reduction in body fat mass by dieting leads to decrease in the hypothalamic PERK 
acitivity, whereas ATF6, BiP and Xbp1 mRNA expression remain induced
85 
. Very recently, 
it was shown that during diet-induced obesity, post translational processing of 
proopiomelanocortin (POMC) mRNA is impaired by ER stress leading to reduced production 
of appetite-suppressing neuropeptide α-melanocyte-stimulating hormone (α-MSH) as this 
hormone’s synthesis is catalyzed by POMC protein179. In this study, researchers demonstrated 
for the first time that in obesity, ER stress contributes in regulation of energy balance through 
altering neuropeptide processing
179
. From all these studies, it can be concluded that excess 
nutrients result in ER stress, which elicits an elaborative adaptive response UPR in 
hypothalamus, muscle, liver and adipose cells in obesity and diabetes. Even the mechanisms 
eliciting this response is not fully clarified, some results are common between these tissues. 
UPR causes inflammation and insulin/leptin resistance in the hypothalamus, liver and fat cells 
through some specific cellular pathways as explained above
83
.  
1.5. Restoring ER function 
After discovering the causality of ER stress in obesity induced metabolic diseases, a search to 
define novel approaches to restoring ER function has begun and the ER is viewed as a 
promising therapeutic target. For example, one of the first trials in rodents consisted of 
applying 4-phenylbutyric acid (PBA), a chemical chaperone which inhibits ER-stress related 
apoptosis, to mouse models of obesity and insulin resistance. PBA has been known to have a 
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protective function in cerebral ischemia and liver ischemia reperfusion injury
86,87
. Studies 
show it is also effective means to reduce ER stress and improve systemic metabolic 
homeostasis and insulin sensitivity in mouse models of obesity
79
. Another chemical 
chaperone, Tauroursodeoxycholic acid (TUDCA) also inhibits ER –stress and improves 
metabolism in mice
79
. Furthermore, TUDCA blocks ER stress-induced apoptosis in human 
liver cells through yet unknown mechanism
88
. Furthermore, chemical chaperone PBA also has 
been studied in another chronic, metabolic disease model, atherosclerosis, in mice. When 
PBA was chronically administered to Apolipoprotein E null (ApoE−/−) mouse model of 
atherosclerosis, ER stress was significantly reduced in atherosclerotic plaques
88
. Treatment 
with PBA reduced PERK phosphorylation and ATF3 expression in macrophages infiltrating 
the atherosclerotic plaques, as well as in isolated macrophages, resulting in protective effect 
against hypercholestrolemic stress
88
. Furthermore, a genetic-deficiency in a macrophage lipid 
chaperone also protected against ER stress and atherosclerosis. In addition, the lipid product 
of aP2 activity, a monounsaturated fatty acid known as palmitoleate, was also found to be 
protective effects against lipid-induced ER stress in macrophages
82
. Diakogiannaki et al., in 
their research also showed that when palmitoleate is given to β cells for 18 hours, 
Tunicamycin and Palmitate induced ER stress can be reduced
89
. Collectively, these data show 
that when palmitate (saturated and toxic) and palmitoleate (monounsaturated and non-toxic) 
are given in a combination treatment, ER stress and cell damage are prevented and meanwhile, 
evidence suggests ER membrane expands less in the combination treatment when compared 
to only palmitate treatment. This result shows that palmitoleate, also quite bioactive when 
given systemically, has protective effect on ER structure and function and a promising dietary 
approach to restoring ER stress in chronic metabolic diseases like atherosclerosis. These and 
other possibilities to reduce ER stress need to be vigilantly tested.  
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Recently in 2010, researchers came up with an important finding that interferon inducible 
double strand RNA dependent protein kinase R (PKR) can respond to excess nutrients, 
pathogens as well as ER stress and elicits a unique inflammatory response and metabolic 
response through regulating insulin action and JNK activity which are important in metabolic 
diseases 
128
. This critical role of PKR enabled researchers search more about small chaperones 
that can regulate its activity for treatment of metabolic diseases such as obesity, insulin 
resistance and diabetes
128
.  
1.6. Structure and Function of Protein Kinase R  
During viral infections, interferon secretion is the early response. In order to maintain 
homeostasis, many specific proteins are activated, particularly by interferons, during this 
process. One such induced protein is the 68 kdA sized, interferon inducible double strand 
RNA activated Protein Kinase R (PKR). PKR is a serine/threonine kinase that is activated not 
only during viral infections but also during ER stress
90,91,92,
. After binding dsRNA, PKR 
dimerizes and auto phosphorylates itself at its threonine 446 and serine 451 sites, leading to 
its full activation. PKR can phosphorylate the eukaryotic initiation factor 2 α (eIF2α) at Serine 
51 site, resulting in general protein translation inhibition, therefore inhibition of viral 
replication
115
. 
 PKR has a distinct structure compared to well-known other kinases. It is known that PKR can 
be activated by binding of double stranded RNA of cellular, viral, or synthetic (such as polyrI: 
polyrC, pIC) origin (longer than 30 nucleotides), to its two N-terminal dsRNA binding motifs 
(DRBMs I and II) in an RNA sequence-independent manner
93
. After the binding of dsRNA, 
PKR dimerizes and auto phosphorylates itself at Threonine 446 and Threonine 451 sites in C-
terminal kinase domain. The DRBMs I and II domains have specific α-β-β-β-α fold and they 
are connected through a 22 nucleotide length linker region (Figure 1.5)
93,94
.  
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Besides dsRNA, PKR is also activated with some cellular activator proteins such as mouse 
Retina and anterior neural fold homeobox protein RAX; and its mammalian homolog p53 
associated cellular protein (PACT)
97,98
. Melanoma differentiation-associated gene-7 protein 
(MDA7) also activates PKR
99
. Adenoviral expression of MDA7 in human lung cancer cells, 
led to activation of PKR and induction of apoptosis
99
. pRB-binding protein E2F-1 (E2F1) 
transcription factor, which is observed in many cancer cell types resulting in apoptosis by 
prolonged general protein translation inhibition, is another inducer of PKR activity,
100
. 
Recently it was shown that PKR can respond to excess nutrients as well as ER stress
128
. 
Nakamura and his colleagues showed that, ER stress inducers such as saturated fatty acid 
palmitate and chemical inducer thapsigargin induce activation of PKR
128
. 
PKR acts as an intermediate in Toll-like receptor signaling. When dsRNA binds to Toll like 
receptor 3 (TLR3), Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), 
Transforming growth factor beta (TGF-β) activated kinase 1 (TAK1) and TGF-beta activated 
kinase 1/MAP3K7 binding protein 2 (TAB2) proteins cumulate around this receptor and form 
a complex
130,131,132
. PKR is also attracted to this complex, which then translocates to cytosol. 
In the cytosol, TAK1 gets phosphorylated by TGF-beta activated kinase 1/MAP3K7 binding 
protein 1 (TAB1)
180
 leading to NF-κB and MAPKs activation. When PKR kinase was 
silenced, poly I:C induced activation of TLR3 dependent activation of NFκB and MAP 
kinases was also inhibited, demonstrating PKR’s significant role in this process130. In TLR4 
dependent but myeloid differentiation primary response 88 (MyD88) adapter protein 
independent pathways, Toll–interleukin 1 receptor (TIR) domain–containing adapter protein 
(TIRAP) interacts with PKR and leads to NF-κB acitvation in TLR4 dependent signaling 
pathways
132
. However, it was also shown that PKR participates in MyD88 dependent TLR 
signaling pathways
133
. Furthermore, a study by Karin et al. demonstrated that PKR is a critical 
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component in TLR-4 signaling pathway dependent macrophage apoptosis due to bacterial 
infection
133
. 
As cellular expression of PKR is a threat for viruses, several viruses have evolved some 
mechanisms for specifically inhibiting PKR. Some viruses result in expression of dsRNA 
binding proteins leading to inhibition of dsRNA-PKR interaction and therefore activation of 
PKR
183
. For example vaccinia virus E3L gene expresses E3L dsRNA binding protein which 
inhibits dsRNA dependent PKR activation through interacting dsRNA and preventing its 
binding to PKR
181
. Some other viruses elicit a unique response for inhibiting PKR through 
forming RNA with secondary structure. This virus-formed RNA binds to PKR but does not 
activate the kinase domain
183
. For instance, the human immunodeficiency virus type 1 (HIV-
1) has trans activation response element (TAR) stem loop structure which is found in all 5’end 
of all HIV-1 mRNA transcripts and these transcripts bind PKR more efficiently then dsRNA 
leading to inhibition of PKR
182
.Some viruses synthesize proteins that interact with PKR and 
inhibits its dimerization and activation
183
. For instance Hepatitis C virus expresses 
Nonstructural protein 5A (NS5A) which interacts with PKR through its kinase domain 
leading to inhibition of its dimerization and activation
183
. Some viruses synthesize proteins 
similar to eIF2α, which is the substrate of PKR128. For example HIV-1 synthesized Trans-
Activator of Transcription protein (Tat) was shown to bind to PKR from the site where 
cellular eIF2α bind183. In addition some cellular proteins also can be utilized by viruses to 
inhibit PKR function. In influenza virus, p58 dissociates from Hsp40 and is activated. Then it 
binds to PKR resulting in inhibition of its dimerization and activation
184
. Therefore, it can be 
concluded that, even PKR is very critical in viral defense, viruses evolved many mechanisms 
in order to inhibit PKR activity.  
Besides its role in cellular response to viral infection, PKR also has a role in cell growth 
control and differentiation, cell cycle regulation and apoptosis it also acts as tumour 
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suppressor
106,117
. In addition to inhibiting general protein translation
50,106,117
, PKR functions in 
many signaling pathways through interaction with specific proteins
94
. For example, PKR 
negatively regulates cell growth; studies have shown that when wild type PKR was 
overexpressed in mammalian or yeast cells, the proliferation rate of these cells decrease 
dramatically and moreover, PKR levels oscillate in different stages of cell cycle
95
. In one 
study, it was shown that PKR interacts with p53 tumour suppressor protein and 
phosphorylates it on serine 392 sites both in vitro and in vivo leading to activation of p53
106
. 
 
 
Figure 1.5. General structure of interferon inducible dsRNA activated Protein Kinase R.  
(reprinted with permission from Hinnebusch et al., (2007). eIF2 kinases provide a new solution to the puzzle of 
substrate specificity. Nature Structural and Molecular Biology)
96
. When PKR is induced with interferons and 
activated with dsRNA, dsRNA binds N-terminal domain of PKR leading to its dimerization and auto 
phosphorylation from its C-terminus 
93,94,96,115. After auto phosphorylation, PKR binds and phosphorylated eIF2α 
through its C-terminal kinase domain whose phosphorylation leads to general translation inhibition and specific 
activation of ATF4 mRNA translation via eIF2α phosphorylation96. 
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Additionally in another research it was showed that PKR knockdown by siRNA in human 
colon cancer cell lines resulted in resistance to therapeutic anti-cancer drugs and under DNA 
damaging conditions, PKR was found to be important for p53 activation
107, 109
. 
PKR is an important kinase in cellular defense and inflammation. It is necessary for mediating 
IRF1 interferon regulatory factor 1 (IRF1) induced cell growth inhibition
108
. Another 
important function of PKR is activation of NF-κB transcription factor via interacting and 
activating IKK
117 
(Figure 1.6). PKR activates IKK complex via its kinase domain, as K296R 
(kinase inactive, dsRNA binding domain active) mutants cannot activate NF- κB pathway109. 
NF-κB transcription factor plays role in important cellular mechanisms including 
inflammation and apoptosis. It activates transcription of apoptosis inducing genes such as Fas 
TNF receptor superfamily member 6 ligand (FasL), Fas, Caspase1, IRF-1 and p53 and 
transcription of inflammatory cytokines
110
. Another factor in inflammation that PKR interacts, 
when inactive, is the signal transducers and activators of transcription protein (STAT-1)
111
. 
When PKR is induced with double stranded RNA (dsRNA) or interferons (IFNs), it 
dissociates from STAT-1, thereby leading to its inactivation
111
. Furthermore, PKR interaction 
with STAT-3 is also necessary for its activation by platelet derived growth factor. (PDGF)
112
. 
In their study Williams et al. showed that PKR is required for the activation of p38 mitogen-
activated protein kinase (MAPK) and JNK by double-stranded RNA, lipopolysaccharide 
(LPS) and proinflammatory cytokine stimulation
113,115,116
. Recently it was also shown that, 
PKR kinase activity is necessary for activation JNK and p38 mitogen activated protein 
kinases
114
.  
PKR also plays a key role in apoptosis. It interacts with Fas (TNFRSF6)-associated via death 
domain protein (FADD), leading to the activation of caspase-8. Active caspsase 8 sequentially 
converts procaspase 3 into active caspase 3, which results in apoptosis. In addition, caspase 8 
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promotes the interaction of Bid with Bax, leading to cytochrome c release from mitochondria 
and with this cytochrome release apoptosome is formed. (Figure 1.6)
117
.  
There are several other known substrates of PKR for example IRS-1 and B56α subunit of 
protein phosphatase 2A
118
. It was shown that PKR phosphorylates IRS-1 on its 307
th
 Serine 
residue, which competes with the tyrosine phosphorylation of IRS-1. Consequently, this can 
lead to insulin resistance through impairment of the insulin signaling pathway 
119
. PKR also 
phosphorylates the catalytic subunit of protein phosphatase 2 A protein’s (PP2A) B56α 
subunit, resulting in PP2A activation and potentially in translational arrest due to PP2A 
mediated dephosphorylation of eukaryotic initiation factor 4 E
118
.  
Like PERK, PKR activates microtubule-associated protein LC3 (light chain 3 (LC3)) through 
eif2α phosphorylation, leading to autophagy124,126. In a recent research, it was also shown that 
Signal transducer and activator of transcription 3 (STAT3) binds to PKR inhibits its activity 
and therefore leads to autophagy. First they showed that STAT3 inhibitors lead to autophagy. 
They observed that inhibition of STAT3 led to overexpression of PKR. They finalize their 
experiments with immunoprecipitation analysis showing specific PKR-STAT3 specific 
interaction leading to autophagy. From their results, they concluded that STAT3 through its 
SH2 domain binds to catalytic domain of PKR, on the site where eIF2α binds, and instead of 
general protein translational inhibition, leads to autophagy. 
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Figure 1.6. PKR induction, activation and its role in different cellular pathways.  
(reprinted with permission from Esteban M., Meurs E.F., Garcia M.A. (2007) The dsRNA protein kinase PKR: 
Virus and cell control* BIOCHIMIE. 89 (2007) 799-811
117
). PKR is an interferon inducible, dsRNA
117
 and 
PACT
98
 activated kinase which activates many cellular signaling pathways. After it auto phosphorylates and 
activates itself, it phosphorylates eIF2α leading to general translational inhibition50. It interacts with TRAF 
complex and leads to phosphorylation of IKK complex, resulting in NFκB activation50. NFκB then translocates 
to nucleus and acts as transcription factor for expression of many inflammatory genes
83,130
. It also interacts with 
FADD leading to activation of caspase 8 and formation of apoptosome complex
50
.  
 
1.7. Role of Protein Kinase R in Inflammation and Metabolic Regulation 
Nakamura et al., demonstrated recently that PKR can regulate the activity of inflammatory c-
Jun terminal kinase
128
. JNK promotes the production of inflammatory cytokines like tumor 
necrosis α and interleukins (IL-1β, IL-6, and IL8) 121. It has been shown that JNK regulates 
the transcription of these pro-inflamatory cytokines through interacting and modulating the 
activity of the transcription factor AP1. (Figure 1.7). Furthermore, through interacting and 
activating IKK complex, PKR activates another inflammatory transcription factor, NF-κB, 
which facilitates the synthesis of cytokines such as TNF-α, interleukins (IL-1β, IL-6, and IL8) 
as well as inducible enzyme cyclooxygenase 2 (Cox-2) that is highly abundant in sites of 
inflammation
121
. In addition PKR stimulates the activated transcription factor 2 (ATF-2), 
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which controls the transcription of pro-inflammatory gene expression. PKR also facilitates 
interferon regulatory factor protein 3 (IRF3) activation through mitochondrial antiviral 
signaling protein (MAVS, IPS1) adapter protein (Figure 1.7)
 125
. Moreover, Lu et al. identified 
unique function of PKR in inflammasome activation. Inflammasome is a multiprotein, 
cytosolic caspase activating protein complex that leads to release of this caspase-1 activated 
cytokines including interleukin IL-1β, IL-18 and high-mobility group box protein 
(HMGB1)
122
.
 
Through their experiments they showed that, stimulation of macrophages with 
inflammasome agonists leads to reduction in PKR auto phosphorylation. Furthermore, when 
PKR is inactivated by genetic deletion, silenced with shRNA or inhibited by specific PKR 
inhibitors, the secretion of IL-1β, IL-18 and HMGB1 were significantly reduced. Through 
immunoprecipitation experiments, they showed direct physical interaction of PKR with NOD-
like receptor (NLR) family pyrin domain containing 3 (NLRP3), NLRP1, NLR family CARD 
domain containing protein 4 (NLRC4), absent in melanoma 2 (AIM2). They were able to 
reconstruct the inflammasome activity in a cell free system by combining recombinant 
NLRP3, PKR, pro-caspase-1 and apoptosis-associated speck-like protein containing a CARD 
(ASC) were present, NLRP3 inflammasome activity was reconstructed (Figure 1.7). 
Therefore it can be concluded that, besides its crucial role in metabolic homeostasis through 
regulating JNK activity and insulin signaling pathway, it also plays a critical role in innate 
immunity activating NLRP1, NLRP3, NLRC4 and AIM2 inflammasomes
122
.  
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Figure 1.7. PKR related inflammation pathways.  
(Reprinted with permission from Kang R.,Tang D. PKR-dependent inflammatory signals
124
. Sci Signal. 2012 Oct 
23;5(247):pe47. doi: 10.1126/scisignal.2003511.) A) PKR senses and responds to PAMPs and DAMPs released 
through infection, injury and necrosis
124
. After activation, PKR interacts with NLRP1, NLRP3, NLRC4 and 
AIM2 inflammasomes resulting in caspase 1 activation and caspase-1 dependent secretion of inflammatory 
cytokines IL-1β, IL-18, and secretion of HMGB1122. B) Besides its role in inflammasome activation, PKR also 
has role in proinflammatory genes’ expression induction, apoptosis and autophagy and it is also activated by 
bacterial and viral infections, cytokines and DNA damage
124
.  
 
Chronic inflammation is hallmark of metabolic diseases such as obesity, diabetes and insulin 
resistance. This low-grade inflammatory response in metabolic diseases has been referred to 
as metaflammation, due to its metabolic or nutrient origin
127
. Analogous to inflammasome a 
metaflammasome complex has been suggested to consist of some proteins which sense excess 
nutrients and metabolites and some proteins that mediate this inflammatory response to the 
metabolic stress. PKR may be viewed as one component of this hypothetical 
metaflammasome complex (Figure 1.8)
 128
. 
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PKR has been shown to respond to nutrients as well as ER stress that is induced by nutrient-
excess and phosphorylates several proteins involved in metabolism such as JNK1
113,128
 and 
IRS1
128,186.  
Nakamura et al. showed that when PKR
-/-
 mouse embryonic fibroblast cells 
(MEFs) were treated with saturated fatty acids (palmitate) ER stress was induced but not JNK. 
As a control, these cells were also treated with thapsigargin and the same results were 
observed leading to the conclusion that, PKR is a necessary, critical component for JNK 
activation in response to ER stress (whether induced by nutrients or chemicals)
128
. It is known 
that PKR and JNK can both phosphorylate IRS1 at 307
th
 serine residue, blocking its tyrosine 
phosphorylation and lead to insulin resistance
128
. PKR not only regulates IRS1, but also IRS2, 
other critical component of insulin signaling pathway. Researchers demonstrated that PKR 
activates FoxO1 which leads to up-regulation of IRS2 gene expression
187
. The constitutively 
expressed FoxO1 is a hallmark in insulin resistance as this constitutive expression results in 
disruption of IRS–PI3K–Akt pathway finally leading to hyperglycemia and glucose 
intolerance
187
. 
Collectively these results demonstrate that both PKR and JNK are activated with excess 
nutrients and ER stress and control a combination of inflammatory and metabolic outcomes
128
. 
Whether PKR and JNK are part of a metabolic inflammasome like complex 
(metaflammasome) that senses the excess of nutrients and couples to inflammation needs to 
be rigorously tested in future experiments
128
.  
Finally, PKR activation increases in obese mice and PKR
-/-
 mice exhibit increased insulin 
sensitivity, glucose tolerance and reduced fasting blood glucose levels, all signs of a better 
systemic metabolic homeostasis.
128,129
. It is thus now appreciated that PKR may play a critical 
role in obesity related insulin resistance and future efforts should be directed to finding 
optimal ways to block PKR-induced inflammation in chronic metabolic diseases.  
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Figure 1.8. Hypothetical Metaflammasome complex and its components.  
(Reprinted with permission from Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N, Gorgun 
CZ, Hotamisligil GS. (2010). Double-stranded RNA-dependent protein kinase links pathogen sensing with stress 
and metabolic homeostasis. Cell. 2010 Feb 5;140(3):338-48. doi: 10.1016/j.cell.2010.01.001
128
.) 
 
1.8. The Relationship between Protein Kinase R and Endoplasmic Reticulum Stress 
ER stress plays a major role in the pathogenesis of metabolic diseases such as obesity, insulin 
resistance, atherosclerosis and diabetes, at least partially by inducing JNK activation and eif2α 
phosphorylation
3,15
. As JNK is also known to be regulated by PKR, Nakamura et al asked 
whether there is a specific role of PKR in ER-stress related metabolic diseases. Dependent on 
thapsigargin and palmitate treatment, ER-stress was induced and simultaneously PKR activity 
was found to increase in response to ER stress both in vitro and in vivo
128
. PKR activity 
increased in primary isolated WT MEFs when they were treated with 500 µM palmitate for 
two hours or with 100nM thapsigargin for one hour. ER stress activation in these experiments 
was confirmed with increased PERK phosphorylation in wild type MEFs
128
. They also 
reported PKR
-/-
 mice have reduced body weight, leptin, adiponectin and blood glucose levels 
compared to PKR
+/+
 mice, when fed with high fat diet
128
. p-eIF2α, JNK1 activity, 
inflammatory cytokines remained lower in High Fat Diet fed PKR
-/-
 when compared to 
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PKR
+/+
  on the same diet. In summary, these findings show that PKR is activated by nutrients, 
ER stress and infectious pathogens and coordinates inflammatory and metabolic responses 
that are critical for metabolic health and disease
128
. 
1.9. Overview of Chemical Genetics and Its Applications 
The major approach that will be introduced in the studies that make this thesis is chemical-
genetics. Chemical genetics is a growing and vibrant field, which aims to study biological 
systems through modulation with small molecules
136
.  The major goal when using this 
technique is to elucidate the molecular mechanisms, cellular pathways and discover novel 
substrates of specific kinases
136
. By combining chemistry with the traditional genetic 
approach, it can be used to analyze the function of a single protein in an organism and in real-
time. Knock-down and knock-out processes are alternative approaches with some major 
disadvantages to chemical-genetics. First, when a gene is knocked down or knocked out, its 
whole function is inhibited. This could lead to unprecedented problems for example if the 
target protein encoded by knocked down gene is a scaffold protein that controls the 
interaction of many other proteins. One can envision that if a scaffold protein is knocked out, 
these association and expression of all the other interacting proteins could change. Therefore 
this knock-out may have indirect and direct effects in cell which could not be differentiated.  
To solve this problem, inducible knockouts and RNA based approaches have been widely 
used, however, these approaches do not initiate a response as quickly as seen in signaling 
pathways. Furthermore, these approaches may also lead to side effects such as off-target 
issues. For example, Causton et al., in their research showed that a temporal shift in yeast 
(from 25 
o
C and 37 
o
C) results in a significant change in the genomic expression
136
. In sum, 
classical genetic methods are not very suitable to study a protein’s function partially because 
of their lack of temporal control. On the contrary, the purely chemical approach could bring 
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about the necessary temporal control over the protein. But this time, a major problem is lack 
of specificity or off-target issues. But a powerful tool called chemical genetics combines the 
ability for temporal control by chemistry with target specificity achieved by genetics
137
. This 
method is subdivided in two groups as forward or reverse chemical genetics
136
. In forward 
chemical genetics method, target identification is performed through phenotype screening 
(from phenotype to protein) whereas in reverse chemical genetics method target identification 
starts with protein, it is isolated and tested against many small molecules.  
Protein kinases act as critical components through activating and maintaining of specific 
signaling pathways that have role in many cellular processes and diseases. Therefore finding 
targets for specific kinases can be a novel therapeutic approach for many diseases. For this 
purpose, recently chemical genetics method has begun to be highly utilized by researchers. To 
identify targets of specific protein kinases, analog sensitive alleles (ASKAs) and novel small 
compounds that regulate kinase activity of these mutants are used
138
. In order to obtain ASKA 
mutants, the candidate protein kinases are engineered (via site-directed mutagenesis) to have a 
slightly enlarged ATP binding cavity that can accommodate bulky ATP analogs
139
. The 
procedure involves determining the ―gatekeeper residue‖ (bulky amino acid residues at 
conserved sites that interact with ATP) by first aligning the sequences of the ATP binding 
cavity of the candidate kinase is with previously identified ASKA mutants of other kinases 
and also modeling the fit between the ASKA mutant and the bulky ATP analog with the help 
of PyMoL and SwissProt softwares. Then the ATP binding pocket is mutated at the identified 
gatekeeper residue via standard site-directed mutagenesis protocol. These large amino acids 
(such as methionine and isoleucine) are basically converted into small side chain hydrophobic 
amino acids (such as glycine and alanine). Importantly, this mutation most of the time does 
not lead to a compromise in the phosphotransfer capacity of the kinase. When combined with 
bulky ATP analogs, the mutant can be temporally regulated. When combined with a tractable 
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ATPgS (that leads to thiophosphate transfer on potential substrates) the ASKA technology 
can be used for disoverin novel, direct targets of the kinases. This involves the mass 
spectroscopic identification of the thiophoshorylated substrates from in vitro and in vivo 
kinase assays using the ASKA mutants. For this method, ASKA mutants are incubated with 
N6-alkylated ATPγS and which thiophosphorylates its substrates. Then p-nitro benzyl 
mesylate (PNBM) alkylation is performed to create thiophosphate esters on substrates. These 
specific thiophosphate esters can be recognized by a rabbit monoclonal thiophosphate ester-
specific antibody and immunoprecipitated. Then mass spectrometry analyses are performed to 
identify the novel substrates (Figure 1.9). 
 
 
Figure 1.9. Strategy for labeling and recognizing individual kinase substrates through ASKA approach.  
(reprinted with permission from Allen JJ., Li M., Brinkworth CS., Paulson JL., Wang D., Hübner A., Chou WH., 
Davis RJ., Burlingame AL., Messing RO, Katayama CD., Hedrick SM, Shokat K.M. (2007). A semisynthetic 
epitope for kinase substrates. Nat Methods. Jun;4(6):511-6.© Nature Publishing Group, 2007 140.) 
 
The ASKA is depicted in pink, and the wild type kinase is depicted in grey. In the first step, analog 
sensitive kinase uses N6-alkylated ATPγS (A*TPγS) to thiophosphorylate its substrates. Then these 
thiophosphorylated substrates are alkylated with PNBM yielding formation thiophosphate esters on 
substrates that are recongnized with thiophosphate ester specific antibodies
140
.  
ASKA strategy is both suitable for in vitro and in vivo applications. It can be directly applied 
to cells via transient or stable transfections of ASKA mutants followed by treatment with ATP 
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analogs in cell culture. For in vivo applications, transgenic mice harboring ASKA mutation 
can be created and ATP analogs (only inhibitors like NAPP1 and NMPP1) can be given to 
them directly through intraperitoneal or subcutaneous injections or drinking water
140
.  
39 
 
2. OBJECTIVES AND RATIONALES 
Interferon inducible double strand RNA dependent protein kinase R (PKR) was shown to be 
activated by over nutrition, pathogens and endoplasmic reticulum (ER) stress
128
. It has been 
shown to play an important role in the pathogenesis of metabolic diseases likely through its 
functions in immune and metabolic responses
128
. When activated PKR phosphorylates 
eukaryotic initiation factor 2 alpha (eIF2α) leading to general translational inhibition and 
likely inhibition of insulin secretion, and phosphorylates IRS-1 at 307
th
 Serine site leading to 
insulin resistance
128
. PKR also regulates activation of inflammatory kinases c-Jun N-terminal 
mitogen activated kinase (JNK) and nuclear factor kappa-light-chain-enhancer of activated B 
cells kinase NFκB, which results in the production of inflammatory cytokines. Very recently, 
another role of PKR in inflammation was demonstrated by researchers. PKR acts as a critical 
component in activation of inflammasomes through physically interacting inflammasome 
components
122
. Therefore it can be concluded that there is through its roles in inflammation, 
ER stress response, and by directly intercepting metabolic signaling PKR appears to be a 
kinase of interest in metabolic diseases research
128
. These properties of PKR show that its 
activity is important for integrating immune and metabolic response which is crucial in 
development and pathogenesis of metabolic diseases
128
. Genetic ablation of PKR in mice 
clearly demonstrated its central role in the development of insulin resistance and type 2 
diabetes
128
. Therefore for metabolic diseases such as obesity, type 2 diabetes, insulin 
resistance and atherosclerosis, PKR or its substrates could become novel targets.  
In my thesis study, I developed a novel chemical-genetic approach in order to temporally and 
specifically control the catalytic activity of PKR during lipid induced ER stress. I created a 
bulky ATP analog sensitive kinase allele (ASKA) mutant, which harbors a slightly enlarged 
ATP binding cavity that can accommodate the bulky analogs of inhibitory and activatory 
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nature. I planned to use this mutant to searches for novel PKR substrates and also to study 
PKR’s role in mediating lipotoxic response. While it was not the scope of my master thesis 
study scope, this mutant will be useful in the future to generate a transgenic mouse model of 
PKR-ASKA mutant, allowing for specific modulation of PKR in chronic metabolic disease 
pathogenesis. 
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3. MATERIALS AND METHODS 
3.1. MATERIALS 
3.1.1. General Laboratory Agents 
The reagents used during this thesis work were purchased from companies such as 
AppliChem (Dermstadt, Germany), SIGMA-ALDRICH (St.Louis, MO, USA), Merck (NJ, 
USA), Fisher Scientific (NJ, US), AMRESCO (Ohio, US). Ethanol, Methanol, Isopropanol 
were purchased from  SIGMA-ALDRICH (St.Louis, MO, USA). DMSO was purchased from 
AppliChem (Dermstadt, Germany). HEPES and Tween were purchased from AMRESCO 
(Ohio, US). Agarose was purchased from PRONA (The European Economic Community). 
Ammonium persulfate was purchased from CARLO ERBA (Italy). Trizma Base and Sodium 
Chloride were purchased from SIGMA-ALDRICH (St.Louis, MO, USA). EDTA and DMSO 
were purchased from AppliChem (Dermstadt, Germany). Tryptone, Yeast extract, Bacto 
Peptone and Agar, were purchased from CONDA (Madrid, Spain). ECL Prime Western Blot 
Detection Kit was purchased from Amersham Pharmacia Biotech Company. (AMERSHAM, 
UK). 40% Acrylamide Reagent was purchased from Fisher BioReagents (Fisher Scientific, NJ, 
US). Ampiccilin, Kanamycin, Bradford and EGTA were purchased from SIGMA-ALDRICH 
(St.Louis, MO, USA). Plasmid mini- and midi-prep kits for plasmid isolation were purchased 
from Invitrogen  by Life Technologies (Germany). Bovine Serum Albumin (BSA) was bought 
from Santa Cruz Biotechnology (Dallas, USA). Polyethylenimine was purchased from 
PolySciences (Warrington, PA, USA). PCR purification kit was purchased from MO-BIO 
Company (CarlsbadCA, USA) and Gel DNA Recovery Kit for DNA extraction from Agarose 
Gel was purchased from ZymoClean (Zymo Research Corporation, CA, USA). High Grade 
Pure Water was purchased from HyClone (Rockford, USA). Dulbecco’s Phosphate Buffered 
Saline (DPBS) was purchased from GIBCO by Life Technologies (Invitrogen, Carlsbad, CA, 
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USA). PageRuler Plus Prestained Protein Ladder and Spectra Multicolor Broad Range Protein 
Ladder were purchased from Thermo Scientific. (Rockford, USA). TRIsure for RNA isolation 
was purchased from BIOLINE (A Meridian Life Science® Company). (London,UK). 
3.1.2. Tissue Culture Materials and Reagents 
Serological Pipettes were purchased from Sarstedt Inc (Newton, NC, USA) and Costar 
Corning Incorporated (NY, USA). Cell culture plates, dishes, scrapers and flasks were 
purchased from Greiner Bio One (Monroe, NC, USA) and Costar Corning Incorporated (NY, 
USA). Dulbecco’s modified Eagle’s Medium was purchased from Thermo Scientific HyClone 
(Rockford, USA) and Lonza (Basel, Switzerland). Rosswell Park Memorial Institute Medium 
(RPMI) was purchased from Lonza (Basel, Switzerland.) Trypsin, Fetal Bovine Serum (FBS) 
and L-Glutamine were purchased from GIBCO (Invitrogen, Carlsbad, CA, USA) and 
HyClone (Rockford, USA) respectively. 
3.1.3. Bacterial Strains 
DH5α Escherichia Coli (E.Coli) Strain was used. 
3.1.4. Enzymes 
KpnI-HF, XhoI, BamHI, HindIII-HF, EcoRI enzymes which were used in restriction enzyme 
digestion during this research, were purchased from New England Biolabs (Ipswich, MA, 
UK). NEB4 Buffer was brought with them and was used during these experiments. For 
cloning and colony PCR, Phire Hot Start enzyme purchased from (Thermo Scientific, Vantaa, 
Finland) and Taq Hot Start Enzyme purchased from Fermentas (Thermo Scientific, Vantaa, 
Finland) were used. Phusion Hot Start II High Fidelity enzyme was used for site-directed 
mutagenesis experiments and it was also purchased from FINNZYMES (Thermo Scientific, 
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Vantaa, Finland). For elimination of methylated bacterial plasmid, DpnI enzyme was used and 
it was bought from Thermo Scientific (Vantaa, Finland). 
3.1.5. Nucleic Acids: 
1 kb DNA ladder was purchased from Fermentas (Thermo Scientific Life Science Research, 
Rockford, USA). Mouse PKR commercial plasmid (PCMV-SPORT6) was obtained from 
Open Biosystems (Thermo Scientific, Rockford, USA). Human PKR commercial plasmid was 
a kind gift from Charles Samuel  (UCSB, USA). pcDNA5F-FLAG and pcDNA3.1 
(Hygromycin Resistant) plasmids were purchased from Invitrogen. (Carlsbad, CA, USA). 
 
3.1.6. Oligo Nucleotides 
 
Table 3.1. The primer list (sequences and Tm) used during this research. 
Primer Sequence Tm 
mPKR 
M328A 
Fwd 
5’ GTGCCTCTTTATTCAAGCGGAATTCTGTGATAAAGG 3’ 61.7 
mPKR 
M328A 
Rev 
5’ CCTTTATCACAGAATTCCGCTTGAATAAAG AGGCAC 3' 61.7 
mPKR 
M328G  
Fwd 
5’ GTGCCTCTTTATCAAGGGGAATTCTGTGATAAAGG 3’ 61.7 
mPKR 
M328 G 
Rev 
5' CCTTTATCACAGAATTCCCCTTGATAAAGAGGCAC  3' 61.7 
hPKR 
M366A 
Fwd 
5’ GTGCCTTTTCATCCAAGCGGAATTCTGTGATAAAGG 3’ 63.2 
hPKR 
M366A 
Rev 
5’ CCTTTATCACAGAATTCCGCTTGGATGAAAAGGCAC 3’ 63.2 
hPKR 
M366G 
Fwd 
5’ 
GTGCCTTTTCATCCAAGGGGAATTCTGTGATAAAGG 3’ 
63.2 
hPKR 
M3666G 
Rev 
5’ CCTTTATCACAGAATTCCCCTTGGATGAAAAGGCAC 3’ 63.2 °C 
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Primer Sequence Tm 
hPKR 
Seq 1 
Fwd 
5' CAGCAGGTTTCTTCATGGAGGAAC 3' 58  °C 
hPKR 
Seq 2 
Fwd 
5' TTATGAACAGTGTGCATCGGG G 3' 57.5 °C 
hPKR 
Seq 3 
Fwd 
5' AGATCTTTGGCACCCAGATTTGAC 3' 57.5 °C 
hPKR 
Seq 4 
Fwd 
5' AGAAGAGGCGAGAAACTAGACAAA G  3’ 56.4 °C 
hPKR 
Seq Rev 
5' GCGGCCAATTGTTTTGCTTCC 3' 58.3 ºC 
mPKR 
Seq1 
Fwd 
5' GACCTCCACATGACAGA GG 3' 54.7 ºC 
mPKR 
Seq2 Fwd 
5' AATATACCTTGGACGCCAGG 3' 54.4 ºC 
mPKR 
Seq3 Fwd 
5' GCTTTGGGCCTTATTCTAGC 3' 53.7 ºC 
mPKR 
Seq Rev 
5' ATGTAGTTACCATAGGGCAAGC 3' 
54.6 ºC 
 
Spliced 
XBP1 For 
5' AGTTAAGAACACGCTTGGGAAT 3' 54.6 ºC 
Spliced 
XBP1 
Rev 
5' AAGATGTTCTGGGGAGGTGAC 3' 56.6 ºC 
 
3.1.7. Electrophoresis, Photograpy, Spectrophotometry and NanoDrop 
Agarose Basica and Agarose Reducta were purchased from PRONA. Gel Electrophoresis tank 
and power supply were bought from Hoefer Inc (Holliston, MA). To determine nucleic acid 
concentration, NanoDrop (ThermoScientific, Wilmington, USA) was used. To determine 
protein concentration, Bradford Reagent (SIGMA-ALDRICH, Germany)  was used and 
measurement was performed with spectrophotometer Beckman Du640 (Beckman Instruments 
Inc, CA, USA). 
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3.1.8. Electroporation 
Electroporation apparatus, Transfection Systems Pipette Station &Pipette and Transfection 
System 10ul and 100 ul Kit were purchased from NEON Transfection System Invitrogen 
(Carlsbad, CA, US).  
3.1.9. Antibodies 
Table 3.2. The list of antibodies that were used during this research; including catalog 
number, working dilution and incubation times. 
Antibody 
Catalog Number and 
Company 
Dilution Incubation Time 
Total PKR 
B-10, sc6282 
Santa Cruz 
1:1000 
1 hour at Room 
Tempeature 
Anti-PKR (phospho 
T446) antibody 
[E120] (ab32036) 
Abcam 
1:1000 (For MEFs) 
1:2000 (For HEKs) 
1 hour at room 
temperature for HEKs 
Overnight incubation for 
MEFs. 
Anti-IRE1 (phospho 
S724) antibody 
(ab48187) 
Abcam 
1:1000 1 hour room temperature 
Beta Tubulin 
(H-235): sc-9104 
Santa Cruz 
1:1000 
1 hour at Room 
Temperature 
Goat Anti-mouse 
IgG-HRP 
sc2005, Santa Cruz 1:5000 
1 hour at Room 
Temperature 
Goat Anti-rabbit 
IgG-HRP 
sc2004, Santa Cruz 1:5000 
1 hour at Room 
Temperature 
Rabbit (polyclonal) 
Anti-PKR [pT451] 
Phosphospecific 
Antibody. 
44668G, Invitrogen 1:1000 
Overnight Incubation 
4°C 
Anti-phospho-PKR 
(Thr451) Antibody | 
07-886 1:1500 
Overnight Incubation at 
4°C 
Thiophosphate Ester (WB 
version) antibody  
RabMAb® 
2686-1 (Abcam) 1:5000 
Overnight incubation at 
4°C 
IRE1α(14C10) Rabbit 
mAb #3294 
Cell Signaling 1:1000 
Overnight incubation at 
4°C 
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3.2. SOLUTIONS AND MEDIA 
3.2.1. General Solutions 
50X Tris-Acetate-EDTA (TAE) 
242 g Trizma Base, 37.2 g EDTA (Tritiplex 3) and 57.1 ml Glacial Acetic Acid was dissolved 
in 1 liter ddH20 for 1 day and autoclaved before use. 
10X Phosphate Buffered Saline (PBS) 
80 g NaCl, 2 g KCl and 15.2 g sodium phosphate dibasic dehydrate and dissolve it in 1 liter 
ddH20 and adjust pH to 6.8. 
Ethidium Bromide 
From 10 mg/ ml stock solution, 1X was used for Agarose Gel Electrophoresis. For 75 ml 
Agarose gel, 5 ul Ethidium Bromide was used. 
3.2.2. Competent Cell Solutions 
CaCl2 solution 
Stock Solutions 
PIPES (Molecular weight = 307.37 g/mol)   pH: 6.4   0.1 M stored at Room Temperature 
CaCl2 (Molecular weight = 147 g/mol)  2 M stored at Room Temperature 
Glycerol    87 % stored at Room Temperature 
The preparation of Mixture for 500 ml from Stock Solutions 
Mix: 
15 ml 2 M CaCl2 (60 mM in the mixture) 
50 ml 0.1 M PIPES (10 mM in the mixture) 
86.2 ml 87% Glycerol  
Mixed with 348.8 ml ddH2O to make volume 500 ml. Then the mixture was autoclaved or 
filtered before use, it was kept at 4ºC. 
47 
 
3.2.3. Bacteria Solutions 
Luria-Bertani Medium (LB medium) 
10 g NaCl, 10 g Bacto-Tryptone, 5 g Bacto-yeast extract were dissolved with 1 liter ddH2O, 
and then was autoclaved.  
Agar medium (For Agar plates) 
100 mg/ml stock solution in ddH2O (1000X). 2 g Ampicciline was dissolved in 20 ml 
autoclaved ddH20. Working solution was 100 μg/ml (1X).  It was filtered, aliquots were made 
and kept at -20ºC. 
Kanamycin (1000X, 50 mg/ml) 
1 g Kanamycin was dissolved in 20 ml autoclaved ddH2O, then was filtered, aliquots were 
made and kept at -20ºC. 
Glycerol Stock Solution 
50% Glycerol 10 ml Glycerol and 10 ml autoclaved ddH2O were mixed and filtered. 
500 μl 50 % Glycerol was mixed with 500 μl bacteria culture, it was vortexed and kept at -80 
ºC. 
3.2.4. Tissue Culture Solutions 
DMEM/RPMI medium 
The complete medium had 10 % Fetal Bovine Serum (FBS) , 1 % L-Glutamine and it was 
stored at 4 ºC. 
1X Phosphate Buffered Solution 
It was purchased from GIBCO (Invitrogen). 
0.25% Trypsin-EDTA (1X), Phenol Red 
It was purchased from GIBCO (Invitrogen). 
L-Glutamine (200 mM) 
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It was purchased from GIBCO (Invitrogen). 
Fetal Bovine Serum (FBS) 
It was purchased from GIBCO (Invitrogen). 
HEPES Buffer (1M) 
It was purchased from SIGMA Life Science. 
Albumin, from Bovine Serum (Fatty Acid Free) 
It was purchased from SIGMA Life Science. 
Thapsigargin 
300 μM Thapsigargin solution was prepared in DMSO as stock solution. Working solution 
was 300 nm. 
4-Amino-1-tert-butyl-3-(1’-naphthyl)pyrazolo[3,4-d]pyrimidine (NaPP1) , 4-Amino-1-
tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine (1-NMPP1) 
NaPP1 and 1-NM-PP1 were purchased from Taconic Artemis. 50 μM NaPP1 and 50 μM 1-
NM-PP1 were dissolved in DMSO. Working solution was 40 μM. 
Palmitic Acid (palmitate) 
500 mM palmitate was dissolved in absolute ethanol. As working solution, 500 μM and 1000 
μM palmitate were dissolved in filtered 1 % BSA (Fatty acid free) containing RPMI.  It was 
heated up to 55ºC, for complete dissolution.  
IRE1 RNAse Inhibitor  
IRE1 RNAse inhibitor (N-[(2-Hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide) 
(STF-083010) was purchased from SIGMA-ALDRICH (St.Louis, MO, USA).  It was 
dissolved in appropriate volume of DMSO to make final concentration 30 mM. The working 
concentration was 300 µM. 
HBS Buffer for Electroporation (Instead of R Buffer) 
Recipe is obtained from Batu Erman (Sabancı University).  
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21 mM commercial HEPES (pH; 7.05) 
137 mM NaCl 
5 mM KCl 
0.7 mM Na2HPO4 
6 mM Glucose  
Solution was filtered before use and is kept at 4°C. 
3.2.5. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and 
Western Blotting Solutions 
For this research, Mini PROTEAN Tetra Cell Western Blotting System (Bio Rad, CA, USA) 
was used for the Western Blot Experiments. The gels used were prepared as 10% and 12 % 
Resolving and 5 % Stacking Gels. 
20% Ammonium persulfate 
1 g Ammonium persulfate was dissolved in 5 ml ddH2O. 
1.5 M Tris-HCl (pH: 8.8) 
54.45 g Tris Base (Trizma) was dissolved in 150 ml ddH2O, pH was adjusted to 8.8 with 1 N 
HCl and volume was made up to 300 ml with ddH2O. It was stored at 4 °C. 
1.5 M Tris-HCl (pH: 6.8) 
12 g Tris Base (Trizma) is dissolved with 60 ml ddH2O, pH was adjusted to 6.8 with 1 N HCl 
and volume was made up to 100 ml with ddH2O. 
10% SDS Solution 
10 g SDS was dissolved in 100 ml ddH2O. 
10% Resolving Gel 
40% Acrylamide mix, 1.5 M Tris-HCl (pH: 8.8), 10% SDS and 20% Ammonium persulfate, 
0.08% TEMED completed with suitable volume of ddH20. 
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5 % Stacking Gel 
40% Acrylamide mix, 1.5 mM Tris-HCl (pH: 6.8), 10% SDS and 20% Ammonium persulfate, 
0.1% TEMED completed with suitable volume of ddH2O. 
5X Running Buffer 
124 mM Tris Base (15 g/liter), 960 mM Glycine (72 g/liter) and 17.4 mM SDS (5 g/liter) 
were dissolved in suitable volume of ddH2O. Working Solution was 1X. 
5X Transfer Buffer 
64.4 mM Glycine (14.5 g/liter), 80 mM Tris Base (29 g/liter), 2.14 mM (1.85 g/liter) SDS, 
were dissolved in suitable volume of ddH2O. Working solution was 1X. (600 ml ddH2O, 200 
ml 5X Transfer Buffer, 200 ml Methanol) 
Phospholysis Buffer 
50 mM HEPES (pH: 7.9), 100 mM NaCl, 4 mM Tetra Sodium pyrophosphate (Na4P2O7), 10 
mM EDTA, 10 mM NaF, 1% Triton, 2 mM Sodium orthovanadate (Na3VO4),  1 mM 
phenylmethanesulfonylfluoride (PMSF), Phosphatase Inhibitor Cocktail 3 (Sigma, P0044) 
and 1X Protease Inhibitor Cocktail (10µM/ ml)  
1M HEPES (pH: 7.9) 
23.83 g HEPES was dissolved in 80ml ddH20, Adjust pH 7.9 with KOH, Complete volume to 
100ml. 
10X Tris Buffered Saline (TBS) 
1.5 M NaCl (87.76 g), 100 mM Trizma Base adjust pH 8.0 with 1N HCl complete volume to 
1 liter with ddH2O 
1X-TBS-T 
450 ml ddH2O, 50 ml TBS, 500 μl Tween were mixed with stirrer. 
Blocking Solution (5 % Bovine Serum Albumin in TBS-T) 
2.5 g Bovine Serum Albumin (Santa Cruz) was dissolved in 50 ml 1X TBS-T. 
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Blocking Solution (5 % Milk in TBS-T or PBS-T) 
2.5 g milk powder was dissolved in 50 ml TBS-T or PBS-T 
10X Phosphate Buffered Saline  
80 g NaCl, 2 g KCl, 15.2 g Na2HPO4.2H2O were dissolved in 1 liter ddH2O and pH was 
adjusted to 6.8. 
1X PBS-T 
450 ml ddH2O, 50 ml PBS, 500 μl Tween were mixed with stirrer 
3.2.6. In Vitro Kinase Assay Solutions 
PKR Kinase Buffer 
 15 mM commercial Hepes (300 µl) (pH7.4), 10 mM MgCl2 (200 µl), 40 mM KCl (800 µl) 
were dissolved in 18.7 ml nuclease free water and the solution is filtered before use. 
3.3. METHODS 
3.3.1. The use of Software Programs 
3.3.1.1. Pymol 
3D hypothetical model of Protein Kinase R (PKR) was created with SwissModel Tools 
program on web and then it was aligned with other kinases (whose crystal structures were 
solved and whose ATP binding pockets were identified previously) in order to find the 
conserved ATP binding residues. Then ASKA mutants of these were created with PyMOL 
program. With help of PyMOL program, wild type and ASKA mutants of PKR were aligned 
with specific kinases in a complex with ATP or 1 NM-PP1.  
For these alignments 2 proteins were used. The first one is GCN2. (Crystal Structure of 
eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP. RSCB ID:1ZYD 
(http://www.rcsb.org/pdb/explore/explore.do?structureId=1ZYD) and Crystal Structure of 
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eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant Complexed with 
AMPPNPRSCB ID: 1ZY5. (http://www.rcsb.org/pdb/explore/explore.do?structureId=1ZYD) 
Padyana et al., 2005)  The second one is TgCDPK1. (Calcium-Dependent Protein Kinase 1 
from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1. 
http://www.rcsb.org/pdb/explore/explore.do?structureId=3I7B) RSCB ID: 3I7B. Ojo et al., 
2010 ). These GCN2-ATP and TgCDPK1 complexes were aligned with PKR WT and PKR 
ASKA mutants via using PyMOL Software program in order to show determine the exact 
ATP binding cavity and show that NMPP1 can perfectly fit in mutants’ ATP pocket whereas 
it cannot fit in wild type form. 
3.3.1.2. BioLign 
BioLign 4.0.6 software program was used for sequence analysis of PKR wild type and 
mutants, according to manufacturer’s recommendations. (http://en.bio-
soft.net/dna/BioLign.html). The sequences for PKR wild type and mutant forms were in 
chromatogram format from the sequencing machine. 
3.3.1.3. ClustalW2 
Homo Sapiens (NP_001129123.1) and Mus Musculus (NP_035293.1) PKR sequences were 
aligned with Mus Musculus PERK (NP_034251.2), Homo Sapiens PERK (NP_004827.4), 
Mus Musculus IRE1 (NP_036146.2), Homo Sapiens IRE1 (NP_001424.3), Mus Musculus 
ERK1 (NP_001157143.1), Homo Sapiens ERK1 (NP_002736.3), Mus Musculus JNK2 
(NP_001157143.1), Homo Sapiens JNK2 (NP_001128516.1), Mus Musculus JNK1 
(NP_057909.1) and Homo Sapiens JNK1 (NP_002741.1) in order to compare and analyze the 
conserved ATP binding pocket sequences (Clustal W2, EMBL-EBI; 
http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
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3.3.1.4. NCBI (National Center Biotechnology Information) 
NCBI website was used in order to reach nucleotide and aminoacid (FASTA) sequence 
information of PKR. 
(http://www.ncbi.nlm.nih.gov/gene?term=(eif2ak2[gene])%20AND%20(Homo%20sapiens[or
gn])%20AND%20alive[prop]%20NOT%20newentry[gene]&sort=weight) 
(http://www.ncbi.nlm.nih.gov/gene?term=(eif2ak2[gene])%20AND%20(Mus%20musculus[o
rgn])%20AND%20alive[prop]%20NOT%20newentry[gene]&sort=weight) 
3.3.1.5. NCBI Open Reading Frame (ORF) Finder 
In order to find Open Reading Frame of interested kinase PKR for designing primers, NCBI 
ORF finder tool was used. (Mus Musculus PKR ORF length: 1547 bp, Homo Sapiens PKR 
ORF length: 1656 bp). (http://www.ncbi.nlm.nih.gov/projects/gorf/). 
3.3.1.6. PrimerX Tool (For Site Directed Mutagenesis Primers Design) 
Mouse PKR (M328A and M328G), Human PKR (M366A and M366G) primers were 
designed via using PrimerX Tool according to manufacturer’s instructions. 
(http://www.bioinformatics.org/primerx/) 
3.3.1.7. NEBcutter V2.0 
NEBcutter tool was used in order to find restriction enzymes that do not cut open reading 
frame of PKR, to use them for cloning process. 
3.3.2. Molecular Cloning Methods 
3.3.2.1. Competent Cell Preparation 
In order to make competent cells, at first, a BIOLABS NeB-5-alpha High efficiency 
competent cell was inoculated into (without antibiotic) 50 ml Luria-Bertani medium (LB) o/n 
in shaker incubator. (37°C, 225 rpm). Then 200 µl of this culture was incoulated in 100 ml 
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LB for dilution. After 1 hour growth, the optical density (OD) of the culture was measured  
via spectrophotometer as previously explained, and until the culture OD reached 0.345 OD. 
Then the culture was divided into 2x50 ml falcons on ice and then they were waited on ice for 
10 minutes. After centrifugation at 1600 g (4°C) for 20 minutes, with ice cold CaCl2 solution 
was resuspended. Then the suspension was centrifuged at 1100 g (4°C) for 10 minutes, then 
the pellet was resuspended in 10 ml ice-cold CaCl2. After these steps, the solution was 
incubated on ice for 30 minutes, and centrifuged again at 1100 g (4°C) for 10 minutes. Finally 
the bacterial pellet was dissolved with 2 ml ice-cold CaCl2 solution and divided in 1.5 ml 
prechilled labeled eppendorf tubes on ice (50 µl/ tubes). Then these eppendorf tubes with 
competent cells were frozen with liquid nitrogen and stored at -20 °C. 
3.3.2.2. Transformation 
In the beginning, 50 ul competent cell (1 eppendorf) was thawed on ice and 2 ul (<100 ng) 
plasmid was added gently in this eppendorf and tapped gently twice. Then, this was waited on 
ice for 30 minutes. After 30 minutes, heat shock was performed at 42 °C for 30 seconds, 
followed by 10 minutes incubation on ice. After this incubation, 200 µl LB was added in 
mixture near flame, and was put in shaker incubator for 1 hour. (at 37°C, 225 rpm). At the 
same time, Agar plates with Ampiccilin were pre-heated in bacteria incubator for 1 hour. 
After the incubation, the mixture was spreaded on two agar plates (150 µl and 50 µl ), and left 
in bacteria incubator between 16-18 hours for colony growth.  
3.3.2.3. Selection of Colonies From Agar Plate and Growth of them in LB for Midi-
prep and Mini-prep  
One single colony was chosen with 20 µl tip; was put in 10 ml LB in a falcon tube with 10 µl 
Ampiccilin for mini-prep, and was put in 100 ml LB in Erlenmeyer with 100 µl Ampiccilin 
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for midi-prep. Then the mixtures were grown overnight in shaker incubator (16 hours, 37 °C, 
225 rpm). 
3.3.2.4. Glycerol Stock Preparation 
500 µl growth bacteria in LB with 1X Ampiccilin was mixed 500 µl with 50%  filtered 
glycerol solution. Then it was frozen and was kept at -80°C for use. 
3.3.2.5. Restriction Enzyme Digestion 
mPKR WT plasmid insert was in PCMV-SPORT6 vector between NotI and SalI restriction. 
To confirm this insert which is approximately 2300 kb, approximately 1000 ng plasmid was 
cut with NotI and SalI enzymes sites for 4 hours at 37°C as recommended. After this 
experiment, samples were run on the 1% Agarose gel and visualized. Then the open reading 
frame of mPKR which is 1547 bp was cloned with KpnI and XhoI cloning primers in order to 
ligate them in mammalian expression vector pcDNA5F which has a FLAG tag. For this 
purpose cloning PCR was performed. After this cloning PCR, PCR purification step was 
applied, in order to obtain pure DNA from the PCR without chemical contaminations. After 
this process, restriction enzyme digestion was performed for both backbone vector 
(pcDNA5F) and mPKR insert. Finally, ligation, transformation and colony PCR were 
performed in order to confirm that mPKR insert was cloned in pcDNA5F successfully. For 
human PKR, insert is 1656 bp and it was in mammalian expression vector pcDNA6. In order 
to confirm that insert was in this plasmid, approximately 1000 ng plasmid was cut with 
BamHI-HF (High Fidelity) and XhoI (High Fidelity) enzymes from NEB Company for 4 
hours. Then samples were run on 1 % Agarose gel, and the results were visualized. After it 
was confirmed that desired hPKR insert was in pcDNA6, this insert was cloned in pcDNA5F 
(FLAG) and pcDNA3.1 (Hygromycin Resistant) mammalian expression vectors with HindIII 
and XhoI enzymes. 
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3.3.2.6. Agarose Gel Electrophoresis 
In order to visualize DNA samples and PCR products, Hoefer SUB10 Mini Plus submarine 
electrophoresis system (Holliston, MA, USA) and Hoefer PS300B 300 Volt Power Supply 
were used. For gel preparation 1X TAE buffer was used and gel concentration changed 
between 0.5%-1% depending on the size of DNA products and the aim of the experiment. For 
gel extraction process, 0.5 % gel was prepared and Agarose Reducta (instead of Basica) was 
used. To prepare the gel, adequate amount of agarose was dissolved in 1X TAE buffer and 
then boiled in microwave until agarose was completely dissolved. Then when the gel cooled 
down Ethidium Bromide was added in the ratio 10 mg/ ml. After that gel was poured and 
DNA samples were mixed with 10X Bromophenol Blue DNA Loading Dye (1:10 Ratio), and 
they were loaded into gel. Samples were run at room temperature for 1 hour at 90V, except 
for gel extraction which was at 100V for 40 minutes. Fermentas #SM0311 Gene Ruler 1 kb 
Ladder was used for visualization and size detection of DNA fragments. Finally the gels were 
visualized under UV light. 
3.3.2.7. Site Directed Mutagenesis 
For Site Directed Mutagenesis, first mutations sites (hPKR M366A, M366G and mPKR 
M328A, M328G) were determined via using PyMOL Software and they were program 
primers specific to mutagenesis site were designed as forward and reverse primers via using 
PrimerX tool. (http://www.bioinformatics.org/primerx/)  
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Table 3.3. Human PKR and Mouse PKR Primers. 
Primer Sequence Tm 
mPKR M328A 
Fwd 
5’ GTGCCTCTTTATTCAAGCGGAATTCTGTGATAAAGG 3’ 61.7 
mPKR M328A 
Rev 
5’ CCTTTATCACAGAATTCCGCTTGAATAAAG AGGCAC 3' 61.7 
mPKR M328G  
Fwd 
5’ GTGCCTCTTTATCAAGGGGAATTCTGTGATAAAGG 3’ 61.7 
mPKR M328G 
Rev 
5' 
CCTTTATCACAGAATTCCCCTTGATAAAGAGGCAC  3' 
61.7 
hPKR M366A 
Fwd 
5’ GTGCCTTTTCATCCAAGCGGAATTCTGTGATAAAGG 3’ 63.2 
hPKR M366A 
Rev 
5’ CCTTTATCACAGAATTCCGCTTGGATGAAAAGGCAC 3’ 63.2 
hPKR M366G 
Fwd 
5’ GTGCCTTTTCATCCAAGGGGAATTCTGTGATAAAGG 3’ 63.2 
hPKR 
M3666G Rev 
5’ CCTTTATCACAGAATTCCCCTTGGATGAAAAGGCAC 3’ 63.2 
 
Site Directed Mutagenesis PCR reactions were first prepared in 10 µl total volume in order to 
confirm the reaction is working, then were prepared in 50 µl total volume. For 10 µl reactions, 
approximately 10 ng, for 50 µl reactions approximately 50 ng DNA template was used. The 
final concentration of site directed mutagenesis primers in reaction is 0.3 µM. 3% DMSO and 
200 µM dNTP as well as 5x Phusion Buffer were added for each sample into reaction mix. 
Phusion Hot Start II, High Fidelity DNA polymerase enzyme, which has proofreading activity, 
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was used in these reactions, in order to reduce the risk of mutations occurring in the template 
DNA. (2 U/µl 0.3 µl50 µl reaction ) Reactions started with initial denaturation step 98°C 
for 5 minutes. Then 25 cycles of amplification was performed at 98°C 35 seconds, (61.5 °C 
for hPKR and 63°C for mPKR) for 30 seconds and 72°C for 4 minutes. (Approximately 30 
s/kb). Final extension was at 72 °C for 10 minutes. After that, 5 µl of the reaction was run on 
gel, in order to confirm reaction worked and specific product was obtained. 
3.3.2.8. DpnI Digestion 
When it was confirmed that expected product was obtained with Site Directed Mutagenesis 
Reaction, 1 µl of DpnI enzyme (20u/ µl) purchased from NEB (Ipswich, MA) was added into 
45 µl reaction in order to eliminate template DNA which was methylated via cutting it. This 
reaction took place at 37°C overnight in incubator. Then in order to inactivate the enzyme, 
heat inactivation process was performed via waiting the samples at 80°C for 20 minutes. 
Finally 2 µl of the reaction was transformed into competent cells. 
3.3.2.9. PCR Purification 
For mPKR experiments, after cloning PCR with KpnI Forward and XhoI reverse primers, 
before restriction enzyme digestion, PCR purification experiment was performed for DNA 
clean up from PCR.  For this experiment PCR purification Kit from MO-BIO Company 
(CarlsbadCA, USA) was used and the experiment was performed according to manufacturer’s 
instructions written on kit protocol. 
3.3.2.10. Gel Extraction. 
After PCR purification, cloned and purified mPKR DNA was cut with Restriction enzymes as 
well as vector backbone (pcDNA5F). Then they were run on 0.5% Agarose Reducta Gel for 
40 minutes at 100V, after that insert and backbone band were sliced under UV light with razor 
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blades and Gel Extraction experiment was performed with ZymoClean Gel DNA Recovery 
kit according to manufacturer’s instructions written on the kit protocol. Finally, samples were 
eluted in 8 µl nuclease free ddH2O and their concentrations were measured with NanoDrop. 
3.3.2.11. Ligation 
To ligate purified hPKR and mPKR inserts into mammalian expression vectors, first 
backbone and insert were cut with restriction enzymes for 4 hours at 37°C, gel extraction was 
performed. The inserts were ligated to backbone (1(plasmid): 7(insert)) ratio with T4 Ligase 
enzyme (Fermentas) (0.5 µl for 10 µl reaction), T4 Ligase Buffer (1 µl for 10 µl reaction) and 
nuclease free water (8 µl) and the samples were incubated overnight at 16- 18°C, next day 
they were transformed into competent cells. 
3.3.2.12. Colony PCR 
Single colonies were chosen with tips of pipettes from the transformation plates and then pcr 
tubes were swiped with these tips. After that these tips were put in LB, for further growth of 
the bacteria in order to make mini prep next day depending on Colony PCR results. PCR 
mixture was prepared as it follows: 1 μl of the 5X Phire enzyme buffer, 0.2 μl forward and 
reverse primers, 0.3 μl DMSO, 0.8 μl MgCl2, 0.2 μl dNTP, 0.2 μl Phire Hot Start Enzyme 
(Finnzymes) in nuclease free water (total reaction volume was 10 μl). As Cloning PCR 
primers were used in this reaction in order to confirm that insert was perfectly ligated in 
backbone, PCR program used in this reaction the was same program with the Cloning PCR 
program. 
3.3.2.13. Miniprep 
For miniprep, Invitrogen PureLink Quick Plasmid Miniprep Kit (Carlsbad, CA, USA) was 
used according to manufacturer’s recommendations written on the kit protocol. In the elution 
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step, isolated DNA was dissolved in approximately 50 μl nuclease free water and its 
concentration was measured with NanoDrop. 
3.3.2.14. Midiprep 
For midiprep, PureLink® HiPure Plasmid Midiprep Kit (Invitrogen, Carlsbad,CA) was used 
according to manufacturer’s recommendations written on the kit protocol. In the elution step, 
isolated DNA was dissolved with suitable volume of nuclease free water (100-200 μl) 
depending on pellet size and its concentration was measured with NanoDrop. 
3.3.3. Tissue Culture Methods 
3.3.3.1. Cell Lines Used in This Research and Their Growth Conditions 
Cell culture mediums used for cell lines in this research were DMEM or RPMI.  293 Human 
Embryonic Kidney (293HEK ) cells, IRE
-/-
 and PKR
-/-
 Mouse Embryonic Fibroblast (MEF) 
cell lines were grown with DMEM whereas THP1 and RAW cells were grown with RPMI.  
Both DMEM and RPMI mediums contained 10% Fetal Bovine Serum (FBS) and 1X-L-
Glutamine. All cells were grown in 37°C incubators. They were checked regularly and they 
were seeded onto new plates when they reached high confluency. 
3.3.3.2. Passage of the Cell Lines 
First cells medium were sucked and they were washed with PBS. Then for 96 mm plate, 1 ml 
Trypsin-EDTA was added and the plate was put in incubator for 3-5 minutes. (10% of the 
total volume).When cells were detached, they were collected in complete medium (DMEM) 
with serological pipettes and were put in 15 ml or 50 ml falcons. Then cells were pipetted 
gently and they were re-seeded on new plates according to appropriate dilutions.  
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3.3.3.3. Freezing and Thawing of the Cells 
When cells reached 70-80 % confluency in plates, first their mediums were sucked. Then they 
were washed with PBS and for detachment suitable volume of Trypsin-EDTA was added in 
these plates, then cells were collected in complete medium and were put in falcons. The 
collected cells were then centrifuged for 7 minutes at 1000 rpm. During this step, freezing mix 
which contains 50 % FBS, 40 % DMEM and 10 % DMSO was prepared. The medium of the 
centrifuged cells were sucked and the pellet was resuspended with this freezing medium. 1 ml 
cell-freezing mix solution was added in each cryovial tube and these cryovial tubes were put 
in -80°C freezer. One day later, one or two cryovials were placed in liquid nitrogen tank. 
For thawing of the frozen cells, the vials that taken from -80°C were incubated in the water 
bath at 37°C for few minutes until they completely thawed. Then 1 ml pre-heated complete 
medium was added into each cryovial, meanwhile 5 ml preheated complete medium was 
poured in each 25 cm
2
 flask that have filtered cap. Then this 2 ml cell and complete medium 
mixed solution rom each cryovial tube was added in each flask. (For PKR -/- MEFs, 
Complete medium with 20% FBS was used as these cells grew slowly.). Then each flask was 
placed in incubator and they were reseeded in 96 mm plates when they become confluent.  
3.3.3.4. Transient Transfection of Cells 
For transient transfection of 293HEK cells, Polyethylenimine (PEI) transfection was 
performed and for Mouse Embyonic Fibroblast Cells (MEFs) Electroporation method was 
performed.  
(http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Cell-
Culture/Transfection/Transfection___Selection-Misc/Neon-Transfection-
System.html?CID=fl-neon) 
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3.3.3.4.1. Polyethylenimine (PEI) transfection 
For transfection of plasmids into 293HEK cells Polyethylenimine (Cat #23966) from 
Polysciences. PEI (1ug/μl) was dissolved in %100 absolute EtOH to make a stock solution. 
For this type of transfection, cells were seeded in 6-well plates one day before transfection at 
40% confluency. The next day, cells in these wells reached 80% confluency and they were 
used for transfection. For 6-well based transfection, 250 µl PEI-DNA mixtures (2 µg DNA 
and 4 µl PEI for each well (1:2 ratio DNA:PEI)) were prepared for each well. Then these 
mixtures were waited for 15 minutes at room temperature. After that step, 750 µl 2% DMEM 
were added on these 250 µl PEI-DNA  mixtures to reach final total volume as 1 ml for each 
well. Finally, old mediums of these wells from 6-well plate were sucked and these 1 ml 
mixtures were added to each well. One day later, PEI transfection medium was replaced with 
fresh complete medium. 
3.3.3.4.2. Transfection by the Electroporation Method 
For this type of transfection method, Transfection Systems Pipette Station & Pipette and 
Transfection System 10ul and 100 ul Kit was purchased from NEON Transfection System 
Invitrogen (Carlsbad, CA, US) was used. In the beginning, optimization experiments (for 24 
well plates) were performed in order to find the most appropriate voltage, pulse width and 
number for each cell lines in this research. In addition, the manufacturer’s recommendations 
were also considered while searching for the suitable conditions. Finally the optimal 
conditions were determined for MEF cell lines as shown in Table 3.4. 
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Table 3.4. Optimal conditions for electroporation of plasmid DNA to MEFs with Neon 
Electroporation Kit. 
The 
cell 
type 
Pulse 
Voltage 
(V) 
Pulse 
Width 
Pulse 
Number 
Cell 
Density 
The 
amount 
of DNA 
Tip 
Type 
The 
amount 
of DNA 
Tip 
Type 
Media 
Type 
MEFs 1050 30 2 5 x 10
5
 2 μg 10 μl 4 μg 100 μl DMEM 
 
For electroporation experiment, at first one day before the electroporation cells were seeded in 
96 mm plate at 40% confluency. Next day, their confluency was approximately ~%70-80 and 
they were ready for transfection. Then they were sucked, washed with PBS, were detached with 
Trypsin-EDTA and collected in complete medium and were quantified with hemocytometer in 
order to obtain 5 x 105 cells for each well. Then suitable amount of cells for transfection were 
collected with complete medium and were centrifuged at 500 rpm for 4 minutes. Then complete 
medium was sucked and cells were resuspended with PBS and cells were centrifuged at 500 rpm 
for 4 minutes. This cell washing step with PBS was performed twice. Finally the pellet was 
dissolved in HBS or R Buffer. (For each transfection 100 µl R buffer was used for 100 µl tip and 
10 µl R buffer was used for 10 µl tip). Before starting the experiment, 2 ml complete medium 
was added in each well in 6 well plate and the plate was pre-heated in incubator during the 
experiment. In the end, electroporation device was used according to manufacturer’s 
recommendations with suitable conditions described in the upper table. After electroporation, 
electroporated cells were divided into each well that had 2 ml preheated complete medium. 
3.3.3.5. Treatment of Cells 
During this research, Thapsigargin, Palmitate, NaPP1, 1-NMPP1, IRE1 RNAse inhibitor 
treatments were applied to 293HEK and MEF cell lines. For treatment, cells were seeded in 
plates according to experiment cell type, and then if it was needed, transient transfection was 
performed. For treatment process, cells’ mediums were sucked and treatments were 
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performed in complete medium that contains suitable amount of chemicals such as 
thapsigargin, palmitate, and bulky ATP analogs which were used from fresh stocks and were 
diluted in complete medium. For negative controls (No treatment), same amount of solvents 
such as ethanol, DMSO and nuclease free water where chemicals were dissolved in were 
added in complete medium. Optimal conditions for treatments were listed in the table below 
next page. 
 
Table 3.5. Optimized and used treatment conditions for cell lines used in this research. 
 
Amount 
(Molarity) 
The solvent 
for treatment 
The solvent for 
dissolving 
Treatment 
duration 
Chemicals used 
for negative 
control 
Thapsigargin 
600 nM 
(mutant) 
experiments 
150 nM (in 
vitro kinase 
assay) 
Complete 
DMEM 
DMSO 1 hour 
DMSO 
(600 nM) 
Palmitate 1000 µM 
RPMI with 1 %  
free fatty acid 
BSA 
Absolute 
Ethanol 
1 hour 
or 
2 hour 
Ethanol 
(1000 µM) 
IRE RNAse 
inhibitor 
300 µM 
1% free fatty 
acid BSA 
RPMI 
DMSO 
2 hour 
pretreatment 1 
and 2 hour with 
palmitate 
DMSO 
and ethanol 
NaPP1 40 µM 
Complete 
DMEM 
DMSO 
Overnight after 
transfection 1 
hour with 
Thapsigargin 
treatment 
DMSO 
1-NMPP1 40 µM 
Complete 
DMEM 
DMSO 
Overnight after 
transfection 1 
hour with 
Thapsigargin 
treatment 
DMSO 
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3.3.4. Total Protein Isolation from Cultured Cells 
In the beginning phospholysis buffer mix was prepared. 100X PMSF, 50X Na3VO4, 100X 
Protease and Phosphatase inhibitor was added in phsopholysis buffer and their final 
concentrations in phospholysis buffer was diluted to 1X.  
Then, plates which were frozen with liquid nitrogen and then kept at -80°C freezer, were put 
on ice, and adequate volume of phospholysis buffer were added on them, then they were 
covered with aluminum folio and waited for 5 minutes, meanwhile they were shaken gently 
on ice. Then the plates were scraped with 1000 µl tip (for 6-well, 12-well plates) or with 
scraper (96 mm, 135 mm plates) and then collected in pre-chilled eppendorfs. Then these 
collected lysed cells were centrifuged at 13000 rpm at 4°C for 10 minutes. After this 
centrifugation step, supernatants were collected in another labeled eppendorfs and were kept 
in ice.  
For Bradford measurements, 49 µl nuclease free water was added in each 2-ml eppendorf and 
1 µl protein sample was added into these eppendorfs. For blank measurement, 1 µl 
phospholysis buffer was added into 49 µl nuclease free water added eppendorf. Then 450 µl 
Bradford Solution (SIGMA-ALDRICH (St.Louis, MO, USA)), was added into each 
eppendorf. Then absorbances of protein samples were determined with spectrophotometer at 
595 nm and concentrations were calculated with help of BSA curve. Dilutions were done 
according to calculations and finally 5X SDS Loading Dye were added to each sample, ratio 
being 1X in total volume. Finally samples were vortexed and boiled for 5 minutes at 95°C. 
They were spinned down and kept at -20°C.  
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3.3.5. Western Blot 
3.3.5.1. Tris-glycine SDS-Polyacrylamide Gel Electrophoresis 
Samples were taken from -20°C and were boiled for 5 minutes at 95°C before loading. 40 to 
80 µg protein was loaded into each well in gel depending on experiment type. 10 µl Protein 
ladder was loaded into one well in order to detect and analyze the expected protein due to its 
size. Tris-glycine SDS-Polyacrylamide Gel Electrophoresis method was used for running 
samples on gel with 1X Running Buffer. Gel concentration depended on size of proteins, in 
this research generally, 10% resolving and 5% stacking gel were used, in some experiments 
12% resolving gel was also used. The samples were run on gel for approximately 35 minutes 
at 80V until they pass to resolving gel from stacking gel and then they were run at 120V until 
the loading dye disappears, and the bands of the ladder opens.  
3.3.5.2. Transfer of Proteins from SDS-Polyacrylamide Gels to Solid Supports 
After running process completed, proteins on gel were transferred onto Thermo Scientific 
PVDF Transfer membranes. Wet Transfer method was used during this step. First membranes 
were soaked in methanol for 10 seconds for activation, and then they were incubated in 1X 
Transfer Buffer. 1X Transfer Buffer was prepared from 5X Transfer Buffer Stock. 600 ml 
ddH2O, 200 ml methanol and 200 ml 5X Transfer Buffer were mixed in order to dilute 5X 
stock to 1X working transfer buffer. Then 3 sponges, 4 filter papers were soaked in 1X 
Transfer Buffer for each sandwich.  
The order of sandwich: 
Black side of the sandwich was down. 
Onto black side, in order: 
•2 sponge 
•1 Whatman 
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•SDS Gel  
•PVDF Membrane (The protein will be in the back face) before usage soak into methanol for 
10 sec to be activated.  
•1 Whatman 
•1Sponge 
were placed. Then the sandwich apparatus was closed. Ice packet was placed in tank with 
ransfer cassette, tank was filled with transfer buffer and was run at 95 V for 2 hours in 4°C 
room. 
3.3.5.3. Blocking, Washing and Binding Antibodies 
After transfer ended, protein transferred membranes were washed with TBS-T quickly for few 
minutes. Then blocking step overnight or 1 hour with 5% TBS-T BSA or 5% TBS-T milk was 
performed. Primary Antibody was prepared in suitable dilutions in 5%TBS-T BSA or 5% 
TBS-T milk (2 ml for each membrane) were put on plate which was surrounded with wet 
towels and left at 4°C overnight or 1 hour at room temperature. For washing, membranes 
were washed with TBS-T (%0.5 tween) 3 times 5,15,5 minutes on shaker in order. Afterward, 
horseradish peroxidase (HRP) conjugated antibodies; anti-mouse or anti-rabbit were used as 
secondary antibody and ratio was determined according to primary antibody efficiency. 
(between 1:5000-1:10000). After 1 hour incubation, membranes were washed with TBS-T 
(%0.5 tween) on shaker for 4 times in order 5,15,5,5.  
3.3.5.4. Detection of Proteins Immobilized on Membranes 
For Detection ECL-Prime (Amersham, UK) was used in 1:1 ratio. 1 ml solution A and 1 ml 
solution B was mixed for each membrane and were put on membrane side that has proteins on. 
Then the membrane was kept on dark for 5 minutes, and developed with X-ray films and 
Developer device. X-ray films were exposed to emitted chemiluminiscent light that came 
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from the reaction of HRP and this reaction led to detection of proteins on X-ray film. 
Exposure duration of X-ray films to membrane depends on primary and secondary antibody 
efficiency and working dilutions of them used during the experiment. 
3.3.6. In Vitro Kinase Assay 
3.3.6.1. Immunoprecipitation 
After cells were lysed with phospholysis buffer, more than 250 µg protein containing cell 
lysates were aliquoted in each tube. Their volumes are adjusted to 500 µl with phospholysis  
buffer. Cell lysate was incubated with 13 µl total PKR antibody. (Santa Cruz B-10, sc6282. 
Dallas. USA). Then cell lysate was immunoprecipitated with antibody for 16 hours 
(overnight) at 4
 oC on tube turner. 50 µL of agarose beads suspension were added in each tube 
and these tubes were incubated for 1 hour at 4 
o
C on tube turner. Then the complexes were 
washed with phospholysis buffer and were centrifuged at 4000 rpm for 3 minutes twice. The 
complexes were then washed with phospholysis buffer three times at 4 
o
C. 
3.3.6.2. In Vitro Kinase Assay 
The supernatants were removed by aspiration. 50 µl PKR kinase buffer was added in each 
tube. The tubes were incubated at 30 
o
C for 30 minutes. 20 mM EDTA was added to each 
tube. 2.5 mM PNBM was added in appropriate controls. Then tubes were incubated at room 
temperature for 1-2 hour on rotator. 5X SDS loading dye (Sample Buffer) were added in each 
tube to stop the reaction. Total volume became approximately 60 µl. Then they were boiled at 
95 
o
C for 5 minutes. Samples were spinned down and were loaded on 10% SDS-gel. 30 µl of 
IP samples were loaded for Western Blot. Then transfer-western protocol was followed with 
Thiophopshate Ester Specific antibody. 
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3.3.7. Total RNA isolation from Cultured Cells 
1 ml Trizol (Trisure) was added to each well of 6 well plate. Then the mixture was pipetted 
up-down, and collected into 1.5 ml eppendorf tube. Then 200 µl chloroform was added in the 
tube, shaked vigorously for 15 seconds, and waited for 3 minutes at room temperature. Then 
the mixture was centrifuged at 14 000 rpm, for 15 minutes at 4°C. After phase separation line 
was detected, the supernatant was taken into another tube. 500 µl isopropanol was added in 
the tube, mixed vigorously, waited for 10 minutes at room temperature, then centrifuged at 14 
000 rpm at 4°C, then isopropanol was sucked carefully not touching to the pellet. Then 1 ml 
75% ethanol was added into the tube for first wash of the pellet. The tube was then 
centrifuged at 8000 rpm for 8 minutes at 4°C. Then the 75% ethanol was sucked and 1 ml  
99.8% ethanol was added to the pellet for second washing and centrifuged at 8000 rpm for 8 
minutes at 4°C.then the supernatant was removed and the pellet was dried under laminar flow 
for few minutes. Then the pellet was dissolved with 20 µl nuclease free water. Then the RNA 
values were measure with nanodrop. 
3.3.8. First Strand c-DNA Synthesis 
First strand cDNAs were synthesized through using Fermentas RevertAid cDNA synthesis Kit 
(GMBH Fermentas, Germany). Then the instructions were followed according to 
manufacturer’s instructions. First RNAs were diluted for cDNA synthesis, then The oligo 
(dT)18 primer, nuclease free water was added and the total volume was obtained up to 10 µl. 
After that the sample was gently mixed, followed by incubation at 65°C for 5 minutes. After 
that 2 µl  reaction buffer,  1 µl  dNTP mix,0.5 µl  RNAase inhibitor,0.5 µl  Revert aid M-Mul 
V Reverse Transcriptase (200u/µl ) and DNA/RNAase free water up to 10 µl,  then the 
samples were mixed gently, and another PCR program was run. In this program samples was 
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incubated for 60 minutes at 42
o
C, then heat inactivation step was performed at 70
 o
C for 5 
minutes. 
3.3.9. Semi Quantitative RT-PCR 
After cDNA was obtained, then semi quantitative PCR was performed for analysis of XBP1 
splicing during palmitate induced ER stress. For semi quantitative RT-PCR, for each reaction, 
2 µl 5x Phire Buffer, 0.5 µl 10 mM dNTP, 0.75 µl MgCl2, 0.5 µl human spliced XBP1  
forward primer, 0.5 µl human spliced XBP1 reverse primer, 4.5 µl nuclease free water and 0.2 
µl Phire enzyme were mixed, making volume approximately 10 µl. PCR program started with 
initial denaturation step at 95 °C for 3 minutes. Then 35 cycles of amplification step was 
performed at 95 °C for 30 seconds, 60 °C for 30 seconds, 72 °C for 45 seconds. Final 
extension was 72 °C for 10 minutes. Then the product was run on 3 % gel for 90 minutes and 
analyzed with UV transilluminator. 
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4. RESULTS 
4.1. Generation of Kinase Switch Mutant of PKR 
Interferon inducible double stranded RNA (dsRNA)-activated Protein Kinase R (PKR), also 
known as eukaryotic initation factor02 alpha kinase-2 (EIF2AK2), is a serine/threonine kinase 
that modulates protein translation through phosphorylating and inhibiting eukaryotic initiation 
factor 2 α (eIF2α)43. Two different isoforms of this gene are encoded by three transcript 
variants. [Provided by RefSeq, Oct 2011]. The transcripts with the accession number 
(NM_001135651.2 and NM_002759.3) encode the longest same transcript (isoform a), 
whereas the transcript with the accession number (NM_001135652.2) encodes the alternate 
in-frame exon deficient transcript (isoform b) (Figure 4.1. PKR’s kinase domain shares 
similarities with three other eIF2α phosphorylating serine/threonine kinases, namely the 
heme-regulated eIF2α kinase (HRI), the amino acid deprivation-activated general control 
nondepressible kinase 2 (GCN2) and the PKR-like eukaryotic initiation factor 2α kinase, 
PERK 
117
.  
In NCBI web site, PKR’s gene identification (ID) is 5610. It locates on short 2p22-p21 arm of 
Chromosome 2: NC_000002.11 between sulfotransferase family cytosolic 6B member 1 
(SULT6B1) gene and G patch domain containing 11 (GPATCH11) gene (Figure 4.2). The 
entire gene is approximately 50 kb in length and contains 17 exons
134
. Translation starts at 
exon 3 and ends at exon 17
134
. The open reading frame of this gene is 1656 bp length and 
encodes 551 aminoacid PKR protein. PKR contains two dsRNA binding domains, one 
serine/threonine kinase catalytic domain (S_TKc) and a protein kinase catalytic domain 
(PK_c like superfamily) (Figure 4.3) (http://www.ncbi.nlm.nih.gov/gene/5610) 
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Figure 4.1. Genomic context and transcripts of PKR. 
 
 
Figure 4.2. Chromosomal location and genomic context of PKR (EIF2AK2) gene in Homo Sapiens. 
 
 
Figure 4.3. The conserved domains of PKR. 
 
Only the crystal structure of Saccharomyces Cerevisiae PKR’s kinase domain has been 
resolved to date
135
. Padyana and colleagues resolved the crystal structure of one of the 
homologous eIF2α phosphorylating kinases, namely GCN2, in 2005141. Since the ATP 
binding pockets of eIF2α phosphorylating kinases are highly conserved among themselves 
and with other kinases, the aformentioned crystal structure was used in this thesis study to 
identify the gatekeeper residues of PKR suitable for chemical-genetic approach. For this 
purpose, PKR amino acid sequence was aligned with other kinases using the ClustalW2 and 
PyMol Software programs. Next, the gate keeper residue in PKR suitable was determined 
based on earlier published gate-keeper mutants in other kinases. (Figure 4.4). The 366
th
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Methionine (M) residue on human PKR was identified as ATP binding gate keeper residue to 
be mutated to a smaller side-chain amino acid in order to generate a kinase-switch mutant of 
PKR (Figure 4.4). 
 
Figure 4.4. Multiple sequence alignment of kinases in order to identify specific gatekeeper residue in PKR 
via using Clustal OMEGA. 
 
Next hypothetical three dimensional (3D) structure of human PKR WT kinase was formed 
with the aid of SwissProt website and mutations were displayed in the PyMoL software. 
(Figure 4.5).  
 
 
Figure 4.5. The hypothetical three dimensional (3D) structure of human PKR WT.  
Left: The gate keeper mutation site, Methionine at 366
th
 position, is depicted with hot pink, in sticks in pretty 
model. Right: The gatekeeper mutation site, Methionine at 366
th
 position is depicted with blue in this surface 
model.  
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To confirm the gate keeper position is correct, wild type human PKR protein was aligned with 
human GCN2 and TgCDPK1 whose crystal structures were resolved in complex with ATP or 
1NM-PP1 (ATP analog) (at 2.00 Å resolution (PDBID:1ZY5); 141and 
http://www.rcsb.org/pdb/explore/explore.do?structureId=1ZY5 ) in complex with ATP or 
1NM-PP1 (ATP analog).via using PyMoL software (Figure 4.6). 
 
 
Figure 4.6. The hypothetical three dimensional (3D) model of PKR aligned with GCN2-ATP complex. 
The hypothetical three dimensional (3D) model of PKR aligned with GCN2-ATP complex. In this figure, the 
alignment was carried out in the PyMoL Software at 2.00 Å resolution for PKR and GCN2 (PDBI ID of GCN2: 
1ZY5)
141
. Red depicts the gate keeper mutation site, green depicts the ATP, and grey is for PKR kinase and blue 
is for GCN2. 
 
As observed above, ATP fits the gate keeper residue of wild type human PKR (Figure 4.6). 
However, the bulky ATP ortholog 1NM-PP1 does not (Figure 4.7). This modeling then 
confirms the exact site of the gatekeeper residue that needs to be mutated to build an ASKA 
mutant of PKR. 
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Figure 4.7. The hypothetical 3D model of PKR aligned with GCN2-1NM-PP1 complex.  
The alignment was carried out in the PyMoL Software at 2.00 Å resolution. The mutation site is depicted in red, 
1NM-PP1 in green, GCN2 in blue and wild type human PKR in grey. 
 
These results demonstrated that potential gatekeeper site for site directed mutagenesis is the 
methionine at 366
th
 position. Since a bulky ATP analog should be accommodated by a larger 
ATP binding cavity, I decided to pursue the mutation at methionine 366 to either alanine or 
glycine. The site of the gatekeeper mutation was further modeled in the PyMoL software, 
where the interaction between the ATP analog (1NM-PP1) or ATP to the mutated kinase and 
WT kinase were visualized. As shown in next page, 1NM-PP1 cannot fit the wild type PKR 
ATP binding cavity, while it is perfectly in fit with the slightly larger, mutated cavity (M366A 
mutation) of ASKA PKR mutant (Figure 4.8 and 4.9). Similar gatekeeper mutations were also 
identified for mPKR as M328G and M328A site (Fig. 4.4). 
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hPKR WT and 1NM-PP1 hPKR WT and ATP 
Figure 4.8. Wild type human PKR in complex with ATP and 1NM-PP1.  
The gate keeper mutation site is depicted with yellow, 1NM-PP1 in red, ATP in blue, and wild type human PKR 
(PKR-WT) in grey. ATP perfectly fits PKR-WT while inhibitory ATP analog 1NM-PP1 does not. 
 
 
  
hPKR M366A and ATP hPKR M366A and 1NM-PP1 
Figure 4.9. Human PKR kinase-switch mutant in complex with 1NM-PP1 or ATP.  
The gate-keeper mutation is depicted in yellow, 1NM-PP1 in red, ATP in blue and human PKR kinase switch 
mutant (M366A) is shown in grey. 1NM-PP1 perfectly fits the enlarged cavity of the M366A mutant. 
 
4.2. Generation of Kinase Switch Mutants of Human PKR by Site Directed Mutagenesis  
First, I proceed to mutate the mouse PKR plasmid, which was purchased from 
Openbiosystems. (Figure 4.10). When the plasmid was received, I confirmed the insert by 
restriction enzyme digestion (the PKR cDNA insert was cloned between NotI and SalI 
restriction sites in the PCMV-SPORT6 vector). Then site directed mutagenesis was performed 
to generate the point mutations for M328A and M328G by a PCR based amplification 
approach. The mutated plasmids were confirmed by sequencing (Figure 4.11). Next, they 
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were transfected into cells to observe expression; however, antibodies specifically raised 
against phosphorylated form of the human PKR did not recognize phosphorylated form of the 
mouse PKR protein. This meant that we would not be able to assess PKR kinase activity 
change by western blotting approach that is practical As a result; I decided to switch to human 
PKR for mutagenesis and chemical genetics approaches since the anti-phospho-PKR antibody 
can recognize this. For this purpose, we obtained the wild type human PKR (in pcDNA6 
plasmid) as a generous gift from Prof. Charles Samuel (University of California at Santa 
Barbara). Human PKR cDNA (1656 bp) was first cut out and subcloned into a mammalian 
expression plasmid carrying a FLAG epitope tag (pCDNA-5F) using the 5’ BamHI and 3’ 
Xho1 restriction sites available on the receiving plasmid. The success of the insertion was 
verified by restriction enzyme digestion of the insert using BamHI and XhoI.  Next, site 
directed mutagenesis was performed to generate the point mutations for PKR M366A and 
M366G and the mutations were confirmed by sequencing. 
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Figure 4.10. The map of mouse PKR plasmid bought from Openbiosystems.  
Mouse PKR cDNA is cloned between NotI and SalI Restriction Sites. 
 
 
 
Figure 4.11. The sequencing result for M328A and mPKR M328G mutation.  
According to sequencing results, Methionine residue at 328
th
 position of mPKR plasmid was successfully 
mutated to either Alanine (top panel) or Glycine (bottom panel). 
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4.3. The expression of wild type and ASKA mutant of PKR in mammalian cells. 
In the chemical-genetics approach, a specific kinase is mutated at a gatekeeper amino asid 
residue in its ATP binding cavity in order to accommodate a bulky ATP analog that is not an 
effective substrate for the wild type kinase. Thus, only the mutated kinase can be followed by 
the activating or inhibiting bulky ATP analogs. A kinase that is regulated in such a manner is 
called the ATP analog sensitive kinase (ASKA)
140
. This ASKA provides a useful tool for 
dissecting the role of specific kinases in signal transduction and biological processes. 
It is known that PKR has several substrates, but its diverse biological roles, especially the 
newly recognized metabolic functions, are not fully explained by the limited number of 
downstream players known. When activated autophosphorylates itself. The most well-known 
substrate of PKR is the eukaryotic initiation factor 2 alpha (eIF2α) 128. PKR also directly 
interacts and phosphorylates IRS1 at 307
th 
Serine residue leading to insulin resistance. Finding 
and targeting other substrates of PKR during metabolic stress can be a novel therapeutic 
approach for metabolic diseases such as obesity, diabetes and insulin resistance
128
. Therefore 
in this thesis study, human M366A and M366G ASKA mutants were generated in order to 
investigate other substrates of PKR during metabolic stress. Once the gatekeeper human PKR 
M366A and M366G mutants were generated with site directed mutagenesis and confirmed by 
sequencing, I transfected them into human embryonic kidney cell lines (HEK293) in order to 
verify their expression (Figure 4.12).  
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Figure 4.12. PKR expression in HEK cells.  
2 µg hPKR WT, hPKR M366A and hPKR M366G and empty mammalian expression vector pcDNA3.1  plasmid 
DNA were transfected to HEK cells by PEI method. They were treated with thapsigargin to induce ER stress. 
PKR Protein levels were detected with total PKR antibody. 
 
As can be observed from the figure 4.12, PKR protein expression and phosphorylation was 
many folds more above that seen in empty vector transfected HEK cells (negative control) 
upon treatment with the ER stress inducer thapsigargin. In summary these results confirm the 
expression of these PKR mutants in mammalian cells. 
4.4. Confirming the Inhibition of PKR ASKA Mutant by the Bulky ATP Inhibitors in 
Mammalian Cells 
After confirming the expression of the PKR mutants, I set forth to determine whether these 
gatekeeper PKR mutants could indeed be inhibited with a bulky ATP inhibitor, NaPP1, and 
therefore, utilized for future applications in signal transduction studies in mammalian cells. 
PKR knockout mouse embryonic fibroblasts (PKR
-/- MEFs) were transfected with 4 µg hPKR 
M366A, hPKR M366G, hPKR WT plasmids or an empty vector (pcDNA3.1) by 
electroporation method. 4 hours after transfection, 40 µM NaPP1 and 40 µM 1NM-PP1 were 
directly given to cells for 16 hours. Then cells were treated with 600nM Thapsigargin to 
induce ER stress for 1 hour.  After treatments, cells were lysed, run on SDS protein gels, 
followed by detection of PKR phosphorylation in Western blots (Figure 4.13, 4.14 and 4.15). 
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Figure 4.13. Bulky ATP analogs NaPP1 and 1NM-PP1 cannot inhibit wild type hPKR.  
4 µg hPKR WT plasmids were transfected to PKR-/- MEF cells with electroporation method. Then, the cells were 
treated with 40 µM NaPP1 and 1NM-PP1, inhibitory ATP analogs 4 hours after transfection and incubated 
overnight. After this incubation, 600 nM Thapsigargin was given to cells for 1 hour. Then cells were lysed and 
PKR phosphorylation, total PKR and Beta Tubulin levels were analyzed from the lysates in Western blot via 
using specific antibodies. 
 
Figure 4.14. NaPP1 inhibits hPKR M366A ASKA mutant, whereas 1NM-PP1 cannot inhibit hPKR 
M366A mutant expressed in PKR-/- MEF cells.  
4 µg hPKR M366A plasmids were transfected to PKR-/- MEF cells by electroporation method. Then, the cells 
were treated with 40 µM NaPP1 or 1NM-PP1 for 4 hours after transfection and incubated overnight. After this 
incubation, 600 nM Thapsigargin (TG) was given to cells for 1 hour. Cells were lysed and PKR phosphorylation, 
total PKR and beta-tubulin levels were analyzed from the lysates in Western blots by using specific antibodies. 
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Figure 4.15. NaPP1 inhibits hPKR M366G ASKA mutant, whereas 1NM-PP1 slightly reduces kinase 
activity of hPKR M366G mutant expressed in PKR-/- MEF cells.  
4 µg hPKR M366G plasmids were transfected to PKR-/- MEF cells by electroporation method.Then, the cells 
were treated with 40 µM NaPP1 or 1NM-PP1 for 4 hours after transfection and incubated overnight. After this 
incubation, 600 nM Thapsigargin (TG) was given to cells for 1 hour. Cells were lysed and PKR phosphorylation, 
total PKR and beta-tubulin levels were analyzed from the lysates in Western blots by using specific antibodies. 
 
The results show that NaPP1 treatment extremely decreased phosphorylation level of PKR to 
in hPKR M366A and hPKR M3666G mutant overexpressed PKR -/- cells. However with the 
same treatment, there was no change in the phosphorylation of hPKR in hPKR WT 
overexpressing PKR -/- cells. 1NM-PP1 did not have an effect on the phosphorylation of 
neither hPKR WT nor hPKR M366A ASKA mutant, but slightly reduces the phosphorylation 
of hPKR M366G mutant in PKR -/- overexpression experiments. 
4.5. Determining Substrates of Human PKR through In Vitro Kinase Assay  
After confirming expression of hPKR ASKA mutant, I set forth to search for potential PKR 
substrates by using ATPS in PKR in vitro kinase assays. HEK cells were transfected with 
hPKR M366A mutant via the PEI method. Next, in vitro kinase assay was performed (using 
ATPS and PNMB for thiophosphateester modification of substrates) followed by Western 
Blot detection of the potential substrates by an anti-thiophosphate ester specific antibodies.  
After stimulation of ER stress with 150 nm thapsigargin treatment for half an hour, cells were 
lysed followed by immunoprecipitation of PKR (using anti-PKR antibody and protein G 
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beads) and in vitro kinase assay. As a result of these procedures, potential substrates were 
detected from the lysates by immunoblotting with the anti- thiophosphate ester specific 
antibody (Figure 4.16). 
 
Figure 4.16. Detection of PKR substrates with in vitro kinase assay.  
After cells were lysed with phospholysis buffer immunoprecipitation was performed with total PKR antibody, 
followed by in vitro kinase assay protocol. 2.5 mM PNBM and 500 µM ATPγS were used in the experiment and 
the substrates were detected through using Thiophosphate Ester Rabbit monoclonal antibody, as ATPγS 
thiophosphorylates ASKA mutants’ substrates and PNBM alkylation yields thiophosphate esters on substrates 
providing robust and accurate detection of specific substrates of PKR under ER stress. The second lane on the 
figure was the negative control showing that PNBM alkylation is necessary for thiophosphate ester specific 
antibody’s recognition of PKR substrates The same membrane was blotted with P-PKR antibody in order to 
confirm that immunoprecipitation with PKR was successful. 
4.6. The Role of IRE1’s Endoribonuclease Function in the Activation of PKR by Lipid-
induced ER Stress 
When ER stress is induced, ER-resident transmebrane Inositol Requiring Enzyme 1 (IRE1) is 
oligomerizes and becomes highly activated through autophosphorylation. Besides its kinase 
activity, IRE1 also possesses an RNAse activity. It splices X- box binding protein 1 (Xbp1) 
mRNA leading to its activation
50,28
.  IRE1 can also nonspecifically cleave some mRNAs on 
the ER membrane, which serves to reduce protein load on the ER and is known as the IRE1 
dependent mRNA decay pathway (RIDD))
50
. PKR is an interferon inducible, double strand 
RNA activated kinase and it can also be activated by ER stress as shown by increased 
phosphorylation activity upon treatment with ER stress inducers Thapsigargin and 
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Palmitate
128
. In this study, we hypothesized that the RNA sensing PKR may be coupled to 
IRE1’s RNase function by ER stress. To test this hypothesis, I utilized a specific IRE1 RNAse 
domain inhibitor to uncouple IRE1’s endoribonuclease function from kinase activity and 
determined its impact of PKR activation by ER stress specifically induced by saturated lipids. 
Based on several optimization trials, I determined 300 µM IRE1 RNAse inhibitor was optimal 
to inhibit IRE1’s RNAse function without changes in the kinase activity. This inhbitor was 
given to HEK cells stressed with 500 µM or 1000 µM palmitate for 2 hours in order to induce 
lipotoxic ER stress response. The lysates were analyzed by immunoblotting with anti 
phopsho-PKR antibody to determine the impact of loss of IRE1 RNAse activity in ER stress 
conditions.  
The results of my experiments showed that the loss of IRE1 RNAse activity significantly 
blocks PKR activation by lipids as demonstrated by reduced phosphorylation of PKR in these 
blots. In addition to these Western Blot experiments, RNA was isolated and Xbp1 mRNA 
splicing was detected by a PCR-based approach. This showed that the inhibitor completely 
blocked IRE1’s RNAse activity at the given doses (Figure 4.17B, 4.17D).  Importantly, the 
functional connection between IRE1 and PKR was dependent on IRE1’s endoribonuclease 
activity. Furthermore, IRE1’s kinase activity was not sufficient to induce PKR 
autophosphorylation (Figure 4.17A, 4.17C). 
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Figure 4.17. The loss of IRE1 RNAse activity blocks PKR activation by lipids.  
HEK293 cells were pre-treated (for 2 hours) with 300 µM IRE1 RNAse inhibitor before the addition of varying 
doses of palmitate (with 1% BSA in 10% RPMI) for 2 hours. (A) The lysates from these cells were analyzed in 
Western blots with anti-phospho-PKR antibody. The same membrane was blotted with anti-phospho-IRE 
antibody in order to demonstrate IRE1 kinase activity does not reduce by the inhibitor treatment. Anti-beta 
tubulin antibody was used to blot for tubulin to demonstrate equal loading. (B) Next, Xbp1 mRNA splicing was 
detected by PCR in order to confirm that palmitate induced ER stress leads to IRE1 RNAse activation and that 
the inhibitor can completely block this. C) Same experiment was repeated in HEK293 cells with 1mM palmitate 
and 300 µM IRE1 RNAse inhibitor treatment for 2 hours and again the same result was obtained. The same 
membrane was blotted with total IRE antibody for equal loading and with P-IRE antibody in order to confirm 
that STF’s inhibitory activity is specific for IRE1 RNAse activity, not leading to decrease in P-IRE levels. D) 
Xbp1 mRNA splicing was detected by PCR in order to confirm that palmitate induced ER stress leads to IRE1 
RNAse activation and that the inhibitor can completely block this. This time treatment was for 6 hours, in order 
to completely activate IRE1 RNase activity with palmitate. (PA: Palmitate, STF-08310: IRE1 RNase Inhibitor). 
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5. DISCUSSION AND CONCLUSION 
The focus of this thesis study is primarily on the role of PKR in mediating the lipid-induced 
ER stress. In order to achieve this goal, I first generated a chemical-genetic tool to modulate 
PKR kinase activity, namely the ATP analog sensitive kinase allele mutant of PKR. My goal 
has been to use this mutant to dissect the specific role and downstream targets of PKR in 
lipid-induced ER stress. In order to begin discovering the PKR substrates in lipid-induced ER 
stress, the PKR ASKA mutant was optimized for in vitro kinase assays and for the first time, 
several downstream substrates of PKR were documented by my initial experiments. 
Furthermore, upstream of PKR, I analyzed a unique relationship between PKR and IRE1 
RNAse activity that are coupled by lipid-induced ER stress in macrophages. 
5.1. Creating an ATP Analog Sensitive Mutant of PKR  
Chemical genetics is a powerful approach, which can be used for dissecting the role of a 
kinase in biological or pathological processes and also for identifying novel kinase substrates. 
The discovery of new substrates, can pave the way to new therapeutical approaches to be 
developed targeting these in the future. In addition, turning on or off the activity of a kinase 
by the addition of a small chemical can also be useful in analyzing signal transduction 
pathways in different cellular or metabolic states. To modulate the kinase activity for 
discovery of specific substrates, a semisynthetic reaction is established. In this reaction, an 
analog sensitive kinase allele (ASKA) mutant is created that can utilize bulky inhibitory ATP 
inhibitors such as NAPP1 or NMPP1 (for blocking kinase activity) as well as bulky ATP 
analogs like N6-ATPS for thio-phosphorylation reactions. Following thio-phosphorylation, 
potential substrates are further alkylated by reacting with p-nitrobenzyl mesylate (PNBM), 
creating thiophosphate ester or a ―semisynthetic epitope‖ on these modified substrates that 
can later be recognized by a highly specific rabbit monoclonal antibody against 
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thiophoshateesters
137
. In this thesis, I used a site-directed mutagenesis approach to generate an 
analog sensitive kinase allele mutant of PKR that can accommodate bulky ATP analogs for 
activation or inhibition. The future perspective of this study is to utilize this mutant to dissect 
PKR’s role in lipid-induced ER stress response and to discover novel substrates of PKR that 
relay the ER stress response to cellular outcomes like inflammation and cell death.  
In the beginning of this thesis, I first identified the potential gatekeeper residues of PKR to 
create suitable mutations that would slightly expand the ATP binding cavity in order to 
accommodate bulky ATP analogs.  Since the ATP binding cavities of kinases are higly 
conserved, PKR’s ATP binding cavity sequence was aligned with other known ASKA 
mutants and the mutation was structurally verified to interact with NMPP1 in 3D modeling in 
PYMOL software (Figure 4.6 and Figure 4.7). These mutation sites were identified as M366A 
and M366G on human PKR and M328A and M328G on mouse PKR. After these mutations, 
it was confirmed by in vitro and in vivo reactions that the kinase activity of these mutants 
remained intact (Figure 4.12). In addition, the results of my experiments showed that hPKR 
M366A and M3666G mutants’ kinase activity can be inhibited by NaPP1 (Figure 4.14 and 
4.15) while wild type hPKR kinase activity remained unchanged (Figure 4.13).  This result 
implied that NaPP1 as a bulky inhibitory ATP analog perfectly fits into the ATP binding 
cavity of hPKR M366A and hPKR M366G ASKA mutant, leading to its kinase activity to be 
inhibited. In the future aims of this project, this mutant can be utilized for studying the impact 
of PKR in lipid-indcued ER stress response (via inhibition by NAPP1) and also for 
identifying potential substrates of PKR during lipid induced ER stress using the bulky ATP 
analog (via reacting with N6benzylATP γS) in kinase assay coupled with mass spectrometric 
analysis of the thiophosphorylated substrates.  
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5.2. Searching Substrates of Human PKR Using the Chemical-Genetic Approach 
To begin optimizing the kinase assays for substrate discovery, in vitro kinase assay were 
optimized for human PKR M366A mutant. In this experiment, HEK cells were transfected 
with hPKR M366A ASKA mutant, followed by thapsigargin treatment to induce a state of ER 
stress. From these lysates, PKR was immunoprecipitated and used for vitro kinase assay in 
reaction with ATPγS. After this, thiophosphorylatied PKR substrates were further alkylated 
with PNBM, yielding thiophosphate esters on the potential substrates. In order to detect the 
novel, thiophosphoesterified substrates, the kinase reactions were run on SDS gels, and 
blotted with a highly specific, rabbit monoclonal anti-thiophosphoester antibody in Western 
Blot experiments (Figure 4.16). For these experiments, PNBM absent kinase assay sample 
were used as a negative control to show that PNBM alkylation is necessary for yielding of 
thiophosphate esters on substrates and recognition by the rabbit monoclonal anti-
thiophosphateester specific antibody. Furthermore, IgG alone control immunoprecipitates 
demonstrated the specificity of the reaction of PKR. The results of these early experiments 
showed for the first time that there are potentially multiple PKR substrates in lipid-induced 
ER stress conditions. In the future, as a continuation of the findings in this thesis, similar 
kinase assay experiments will be coupled with mass-spectroscopic identification of the 
thiophosphateesterified substrates. Furthermore, to demonstrate the newly identified proteins 
are real subtrates of PKR, they will be reacted with PKR in in vitro and in vivo kinase 
reactions. 
5.3. Coupling of IRE1 Endoribonuclease Activity with PKR by Lipid-induced ER Stress 
IRE1 is historically the first discovered and only conserved arm of the UPR from yeast to 
mammals. It has a major role in controlling the expression of key ER chaperone proteins and 
activatites by splicing XBP1 mRNA to generate an active transcription factor
28
. In my 
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preliminary observations, I noted a marked difference in the activating PKR phosphoryation 
at 446
th
 threonine site between IRE
-/- 
mouse embryonic fibroblasts (MEF) stably expressing 
either wild type or RNAse inactive PKR mutant (PKR_K907A). However, since the 
commercially designed antibodies against phospho-PKR (P-PKR) poorly recognize the mouse 
form, in my follow up experiments I had to revert to overexpression of the human PKR 
plasmid in mouse embryonic fibroblasts. But, the transfection or electroporation of plasmids 
into stable cell lines proved to be extremely difficult with very slight expression of hPKR 
protein that could be recognized weakly by the commercial antibodies. Because of these 
technical challenges, I changed my experimental approach to study IRE1’s impact on PKR 
and decided to utilize a specific and widely used IRE1 RNAse inhibitor in my cellular 
experiments. I first defined the experimental conditions for optimal the inhbition of IRE1’s 
RNAse activity in the human embyonic kidney cell line, HEK293 cells.  Inhibition of IRE1 
RNAse activity by the inhibitor resulted in a significant block in lipid’s ability to induce PKR 
phosphorylation and thereby it’s kinase activity (determined by autophosporylation of PKR) 
(Fig. 4.17). Together with my early observations in IRE
-/- 
MEF cell lines, this result strongly 
argues that IRE1’s RNAse activity provides an essential input for PKR to respond to lipid 
stress. 
The outcome of the above studies are important, because they show that in ER stress response 
to lipids, lots of kinases such as IRE and PKR are coordinated and interact, and moreover, 
they can regulate each other’s activities. It is also interesting that IRE1 RNAse activity is 
required for PKR activity and suggests an RNA connection between IRE1 and PKR in lipid-
induced ER stress. Very recently, Papa et al showed that IRE1α RNAse domain leads to fast 
decay of pre-miRNAs 17, 34, 96 and 125, the mature forms of which suppress Caspase-2 
mRNA translation and thereby, apopotosis
58
.  Therefore, in the light of these recent findings 
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and my findings, future effort should be concentrated on defining potential noncoding RNA 
targets of IRE1 that couple it to PKR activation in lipid-induced ER stress.  
In conclusion, the experimental tools generated during this thesis study were instrumental in 
discovering there are multiple substrates of PKR in lipid induced ER stress. The future studies 
stemming from my findings should be able to determine the identities of these new PKR 
targets by coupling chemical-genetics with proteomic methods. Potential novel substrates of 
PKR can evolve into specific therapeutic targets against metabolic and inflammatory diseases 
such as diabetes, insulin resistance and obesity. In addition, the results of my thesis study 
unraveled a surprising function of IRE1 RNAse domain in activating the PKR kinase activity. 
The future perspective of these studies includes the identification of RNA species regulated 
by IRE1’s RNAse output and that can bind and regulate PKR or its partners. Ultimately, the 
discovery of specific miRNAs that can be targeted to uncouple IRE1 from PKR may become 
another novel therapeutic approach in metabolic diseases. 
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6. FUTURE PERSPECTIVES 
In this thesis study, I generated a functional ASKA mutant of human PKR that is suitable for 
chemical-genetics approach to delineate signal transduction pathways. As a result of my 
studies, I successfully created two ASKA mutants of human PKR, M366A and M3666G, and 
demonstrated temporal and specific inhibition of their kinase activity with bulky ATP 
inihibitors. These mutants can be used in in vitro kinase and in vivo kinase assay experiments 
coupled to proteomics for substrate discovery. After identification of potential substrates of 
PKR, their function and role in ER-stress signal transduction pathways should be analyzed 
through further in vitro and in vivo kinase assays using the potential substrate. Moreover, 
creation of a transgenic mouse model with the ASKA mutant of PKR could be valuable to 
dissect its role in metabolic disease. Other studies showed it is possible to administer NaPP1 
(subcutaneously, intraperitoneally and orally) to mice for temporal and specific control of the 
kinase activity in vivo. This could become a useful tool in studying the specific function of 
PKR in lipid induced ER stress in chronic metabolic diseases, especially because two separate 
partial knock-outs of PKR show opposing metabolic profiles128. Furthermore, by analyzing 
PKR’s specific substrate preferences during metabolic disease pathogenesis, new and more 
specific therapeutical approaches may be generated against these diseases.  
Secondly, the outcome of my studies illuminates a unique relationship between IRE1 and 
PKR for the first time. By specifically inhbiting the IRE1’s RNAse activity with an 
established IRE1 RNAse inhibitor, I showed that IRE1’s RNAse activity is required for PKR 
kinase activation by lipids, this function of IRE1 RNAse domain was previously unsuspected 
and should be validated through several approaches. For instance, IRE1 ASKA mutant can be 
transfected to HEK cells with IRE WT, and its kinase and RNAse activity can be uncoupled 
by the addition of 1-NMPP1 bulky ATP analog, that inhibits the kinase domain while 
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specifically activating the endoribonuclease domain. In these cells, a comparison of PKR 
autophosphorylation will tell us whether IRE1’s kinase domain is required and whether 
RNAse domain is sufficient in activation of PKR. Furthermore, since PKR was recently 
shown to be associated with the inflammasome and lipids can induce both ER stress and PKR, 
the IRE1 RNAse inhibitor (or IRE1 specific siRNA validated in our laboratory) can also be 
utilized to dissect the role of PKR in IRE1 induced inflammasome activation. For instance, 
experiments can be designed so that IRE1 dependent inflammasome activity can be analyzed 
after treatment with IRE1 RNAse inhibitor in primary bone marrow derived mouse 
macrophages induced by lipids. Alternatively, the ASKA mutant of IRE1 can be used with 
NMPP1 to induce its RNAse activity and together with LPS to stimulate the inflammasome in 
cells where PKR is inhibited via siRNA-induced knock down. Moreover, the overexpession 
of IRE1 ASKA mutant in PKR-ASKA primary bone marrow derived macrophages (obtained 
from a future PKR ASKA transgenic mouse) where NMPP1 will be used to turn on IRE1 
activity but turn of both IRE1 and PKR kinase activities can be instrumental to dissect PKR’s 
role in LPS and IRE1 induced inflammasome activation. Many more experiments can be 
envisioned using one or a combination of these mutants and tools to dissect complex 
interactions in ER stress response that are tied to cellular outcomes like inflammation and 
death. Through targeting the specific molecular interaction points between these two ER 
stress dependent kinases, it may be possible in the future to design new therapeutical 
approaches against metabolic diseases such as insulin resistance, fatty liver, diabetes, 
atherosclerosis and obesity. 
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